urlscan.io logo urlscan.io
SecurityTrails logo

www.empr.com Open in urlscan Pro
3.226.58.85  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: http://link.email.empr.com/a/1323/click/67302/5059933/26045578ac672cf0043e394ea957a021b8adcff9/4450e63aa15b338fb174a6c27fc8...
Effective URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-t...
Submission: On September 08 via api from US
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 47 IPs in 7 countries across 34 domains to perform 242 HTTP transactions. The main IP is 3.226.58.85, located in Ashburn, United States and belongs to AMAZON-AES - Amazon.com, Inc., US. The main domain is www.empr.com.
TLS certificate: Issued by RapidSSL RSA CA 2018 on January 16th 2019. Valid for: 2 years.
This is the only time www.empr.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 2 35.238.92.4 15169 (GOOGLE)
35 3.226.58.85 14618 (AMAZON-AES)
24 94.31.29.64 33438 (HIGHWINDS2)
3 2a00:1450:400... 15169 (GOOGLE)
1 93.184.220.113 15133 (EDGECAST)
9 2a00:1450:400... 15169 (GOOGLE)
4 52.216.115.21 16509 (AMAZON-02)
1 2a00:1450:400... 15169 (GOOGLE)
1 2600:9000:205... 16509 (AMAZON-02)
10 172.217.22.98 15169 (GOOGLE)
1 2606:4700::68... 13335 (CLOUDFLAR...)
1 7 2a00:1450:400... 15169 (GOOGLE)
1 4 104.111.214.103 16625 (AKAMAI-AS)
5 2a00:1450:400... 15169 (GOOGLE)
66 2606:4700:20:... 13335 (CLOUDFLAR...)
1 35.174.96.0 14618 (AMAZON-AES)
1 143.204.214.37 16509 (AMAZON-02)
3 2a03:2880:f02... 32934 (FACEBOOK)
2 2 52.206.48.92 14618 (AMAZON-AES)
2 2 35.227.248.159 15169 (GOOGLE)
1 34.225.65.223 14618 (AMAZON-AES)
1 143.204.207.113 16509 (AMAZON-02)
3 52.1.219.33 14618 (AMAZON-AES)
2 8 34.252.62.73 16509 (AMAZON-02)
1 1 2a00:1450:400... 15169 (GOOGLE)
1 3 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
1 143.204.214.113 16509 (AMAZON-02)
3 2a03:2880:f12... 32934 (FACEBOOK)
1 34.233.109.111 14618 (AMAZON-AES)
1 1 104.111.241.32 16625 (AKAMAI-AS)
2 2 35.190.72.21 15169 (GOOGLE)
2 2 2.18.233.201 16625 (AKAMAI-AS)
2 2 54.76.79.46 16509 (AMAZON-02)
2 3 18.195.52.121 16509 (AMAZON-02)
2 35.227.192.113 15169 (GOOGLE)
4 35.172.78.117 14618 (AMAZON-AES)
1 52.4.150.177 14618 (AMAZON-AES)
4 34.197.62.58 14618 (AMAZON-AES)
4 2600:9000:205... 16509 (AMAZON-02)
2 143.204.214.77 16509 (AMAZON-02)
1 3.248.146.79 16509 (AMAZON-02)
4 2600:1f14:e96... 16509 (AMAZON-02)
1 52.51.120.75 16509 (AMAZON-02)
7 2a00:1450:400... 15169 (GOOGLE)
1 4 2600:1f14:e96... 16509 (AMAZON-02)
1 4 2600:1f14:e96... 16509 (AMAZON-02)
1 4 2600:1f14:e96... 16509 (AMAZON-02)
1 4 2600:1f14:e96... 16509 (AMAZON-02)
1 52.13.54.247 16509 (AMAZON-02)
1 54.185.17.100 16509 (AMAZON-02)
1 34.220.54.177 16509 (AMAZON-02)
1 35.164.230.125 16509 (AMAZON-02)
242 47
2    35.238.92.4 (United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 4.92.238.35.bc.googleusercontent.com
link.email.empr.com
mpct1.maropost.com
35    3.226.58.85 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-3-226-58-85.compute-1.amazonaws.com
www.empr.com
24    94.31.29.64 (United Kingdom)

ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US)
PTR: 94.31.29.64.IPYX-077437-ZYO.above.net
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
3    2a00:1450:4001:809::200a (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
fonts.googleapis.com
1    93.184.220.113 (London, United Kingdom)

ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US)
tags.crwdcntrl.net
9    2a00:1450:4001:81d::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
www.googletagservices.com
adservice.google.de
adservice.google.com
pagead2.googlesyndication.com
4    52.216.115.21 (Ashburn, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: s3-1.amazonaws.com
s3.amazonaws.com
1    2a00:1450:4001:819::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
www.googletagmanager.com
1    2600:9000:2057:b600:1b:fadc:b780:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
content.maropost.com
10    172.217.22.98 (United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: fra15s18-in-f98.1e100.net
securepubads.g.doubleclick.net
1    2606:4700::6813:9408 (United States)

ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US)
script.crazyegg.com
7    2a00:1450:4001:825::200e (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
www.google-analytics.com
4    104.111.214.103 (Netherlands)

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a104-111-214-103.deploy.static.akamaitechnologies.com
sb.scorecardresearch.com
5    2a00:1450:4001:825::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
fonts.gstatic.com
66    2606:4700:20::6819:5365 (United States)

ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US)
c.lytics.io
1    35.174.96.0 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-35-174-96-0.compute-1.amazonaws.com
accounts.haymarketmedia.com
1    143.204.214.37 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-143-204-214-37.fra53.r.cloudfront.net
d31qbv1cthcecs.cloudfront.net
3    2a03:2880:f02d:12:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)
connect.facebook.net
2    52.206.48.92 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-206-48-92.compute-1.amazonaws.com
mt.sitomobile.com
2    35.227.248.159 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 159.248.227.35.bc.googleusercontent.com
pixel.tapad.com
1    34.225.65.223 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-34-225-65-223.compute-1.amazonaws.com
sp.sitomobile.com
1    143.204.207.113 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-143-204-207-113.fra53.r.cloudfront.net
js.adsrvr.org
3    52.1.219.33 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-1-219-33.compute-1.amazonaws.com
www.medtargetsystem.com
8    34.252.62.73 (Dublin, Ireland)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
ml314.com
1    2a00:1450:400c:c06::9a (Brussels, Belgium)

ASN15169 (GOOGLE - Google LLC, US)
stats.g.doubleclick.net
3    2a00:1450:4001:81c::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
www.google.com
1    2a00:1450:4001:81e::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
www.google.de
1    143.204.214.113 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-143-204-214-113.fra53.r.cloudfront.net
certify.alexametrics.com
3    2a03:2880:f12d:83:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK - Facebook, Inc., US)
www.facebook.com
1    34.233.109.111 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-34-233-109-111.compute-1.amazonaws.com
in.ml314.com
1    104.111.241.32 (Netherlands)

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a104-111-241-32.deploy.static.akamaitechnologies.com
tags.bluekai.com
2    35.190.72.21 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 21.72.190.35.bc.googleusercontent.com
idsync.rlcdn.com
2    2.18.233.201 (Ascension Island)

ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US)
PTR: a2-18-233-201.deploy.static.akamaitechnologies.com
pixel.mathtag.com
2    54.76.79.46 (Dublin, Ireland)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-54-76-79-46.eu-west-1.compute.amazonaws.com
sync.crwdcntrl.net
3    18.195.52.121 (Frankfurt am Main, Germany)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-18-195-52-121.eu-central-1.compute.amazonaws.com
ps.eyeota.net
2    35.227.192.113 (Mountain View, United States)

ASN15169 (GOOGLE - Google LLC, US)
PTR: 113.192.227.35.bc.googleusercontent.com
api.lytics.io
4    35.172.78.117 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-35-172-78-117.compute-1.amazonaws.com
subapi.haymarketmedia.com
1    52.4.150.177 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-52-4-150-177.compute-1.amazonaws.com
www.medicalbag.com
4    34.197.62.58 (Ashburn, United States)

ASN14618 (AMAZON-AES - Amazon.com, Inc., US)
PTR: ec2-34-197-62-58.compute-1.amazonaws.com
ads.spotible.com
4    2600:9000:2057:5e00:16:bc48:4dc0:93a1 (United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
adtrackapi.haymarketmedia.com
2    143.204.214.77 (Seattle, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: server-143-204-214-77.fra53.r.cloudfront.net
cdn1.spotible.com
1    3.248.146.79 (Dublin, Ireland)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-3-248-146-79.eu-west-1.compute.amazonaws.com
bcp.crwdcntrl.net
4    2600:1f14:e96:5802:3864:1186:98a:22d7 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
api.b2c.com
1    52.51.120.75 (Dublin, Ireland)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-52-51-120-75.eu-west-1.compute.amazonaws.com
insight.adsrvr.org
7    2a00:1450:4001:825::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE - Google LLC, US)
tpc.googlesyndication.com
4    2600:1f14:e96:5802:4696:4121:90e8:18d3 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
api-52-13-54-247.b2c.com
4    2600:1f14:e96:5800:1332:efe2:4c8b:e1bc (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
api-54-185-17-100.b2c.com
4    2600:1f14:e96:5802:a3d2:ff9c:62:f338 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
api-34-220-54-177.b2c.com
4    2600:1f14:e96:5800:82de:3dbd:aba5:8158 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
api-35-164-230-125.b2c.com
1    52.13.54.247 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-52-13-54-247.us-west-2.compute.amazonaws.com
api-52-13-54-247.b2c.com
1    54.185.17.100 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-54-185-17-100.us-west-2.compute.amazonaws.com
api-54-185-17-100.b2c.com
1    34.220.54.177 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-34-220-54-177.us-west-2.compute.amazonaws.com
api-34-220-54-177.b2c.com
1    35.164.230.125 (Boardman, United States)

ASN16509 (AMAZON-02 - Amazon.com, Inc., US)
PTR: ec2-35-164-230-125.us-west-2.compute.amazonaws.com
api-35-164-230-125.b2c.com
Apex Domain
Subdomains		 Transfer
68 lytics.io
c.lytics.io
api.lytics.io
82 KB
36 empr.com
link.email.empr.com
www.empr.com
2 MB
24 b2c.com
api.b2c.com
api-52-13-54-247.b2c.com
api-54-185-17-100.b2c.com
api-34-220-54-177.b2c.com
api-35-164-230-125.b2c.com
28 KB
24 netdna-ssl.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
270 KB
11 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
104 KB
9 googlesyndication.com
tpc.googlesyndication.com Failed
pagead2.googlesyndication.com
176 KB
9 ml314.com
ml314.com
in.ml314.com
17 KB
9 haymarketmedia.com
accounts.haymarketmedia.com
subapi.haymarketmedia.com
adtrackapi.haymarketmedia.com
12 KB
7 google-analytics.com
www.google-analytics.com
57 KB
6 spotible.com
ads.spotible.com
cdn1.spotible.com
709 KB
5 gstatic.com
fonts.gstatic.com
65 KB
5 googletagservices.com
www.googletagservices.com
125 KB
4 scorecardresearch.com
sb.scorecardresearch.com
3 KB
4 google.com
adservice.google.com
www.google.com
931 B
4 amazonaws.com
s3.amazonaws.com
2 MB
4 crwdcntrl.net
tags.crwdcntrl.net
sync.crwdcntrl.net
bcp.crwdcntrl.net
13 KB
3 eyeota.net
ps.eyeota.net
1 KB
3 facebook.com
www.facebook.com
324 B
3 medtargetsystem.com
www.medtargetsystem.com
52 KB
3 sitomobile.com
mt.sitomobile.com
sp.sitomobile.com
2 KB
3 facebook.net
connect.facebook.net
120 KB
3 googleapis.com
fonts.googleapis.com
2 KB
2 mathtag.com
pixel.mathtag.com
1 KB
2 rlcdn.com
idsync.rlcdn.com
846 B
2 adsrvr.org
js.adsrvr.org
insight.adsrvr.org
2 KB
2 tapad.com
pixel.tapad.com
844 B
2 google.de
adservice.google.de
www.google.de
850 B
2 maropost.com
content.maropost.com
mpct1.maropost.com
5 KB
1 medicalbag.com
www.medicalbag.com
179 KB
1 bluekai.com
tags.bluekai.com
856 B
1 alexametrics.com
certify.alexametrics.com
553 B
1 cloudfront.net
d31qbv1cthcecs.cloudfront.net
2 KB
1 crazyegg.com
script.crazyegg.com
28 KB
1 googletagmanager.com
www.googletagmanager.com
34 KB
242 34
Domain Requested by
66 c.lytics.io 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
c.lytics.io
www.empr.com
35 www.empr.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
24 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
10 securepubads.g.doubleclick.net www.googletagservices.com
securepubads.g.doubleclick.net
www.empr.com
8 ml314.com 2 redirects www.empr.com
ml314.com
7 tpc.googlesyndication.com securepubads.g.doubleclick.net
7 www.google-analytics.com 1 redirects www.googletagmanager.com
www.google-analytics.com
5 api-35-164-230-125.b2c.com 1 redirects www.empr.com
5 api-34-220-54-177.b2c.com 1 redirects www.empr.com
5 api-54-185-17-100.b2c.com 1 redirects www.empr.com
5 api-52-13-54-247.b2c.com 1 redirects www.empr.com
5 fonts.gstatic.com www.empr.com
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
5 www.googletagservices.com www.empr.com
securepubads.g.doubleclick.net
4 api.b2c.com www.empr.com
securepubads.g.doubleclick.net
4 adtrackapi.haymarketmedia.com s3.amazonaws.com
4 ads.spotible.com www.empr.com
ads.spotible.com
4 subapi.haymarketmedia.com s3.amazonaws.com
4 sb.scorecardresearch.com 1 redirects www.empr.com
www.googletagmanager.com
4 s3.amazonaws.com www.empr.com
3 ps.eyeota.net 2 redirects www.empr.com
3 www.facebook.com www.empr.com
connect.facebook.net
3 www.google.com 1 redirects securepubads.g.doubleclick.net
3 www.medtargetsystem.com www.empr.com
www.medtargetsystem.com
3 connect.facebook.net www.empr.com
connect.facebook.net
3 fonts.googleapis.com www.empr.com
s3.amazonaws.com
2 pagead2.googlesyndication.com www.empr.com
2 cdn1.spotible.com www.empr.com
2 api.lytics.io c.lytics.io
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
2 sync.crwdcntrl.net 2 redirects
2 pixel.mathtag.com 2 redirects
2 idsync.rlcdn.com 2 redirects
2 pixel.tapad.com 2 redirects
2 mt.sitomobile.com 2 redirects
1 insight.adsrvr.org js.adsrvr.org
1 bcp.crwdcntrl.net tags.crwdcntrl.net
1 www.medicalbag.com www.empr.com
1 tags.bluekai.com 1 redirects
1 in.ml314.com ml314.com
1 certify.alexametrics.com www.empr.com
1 www.google.de www.empr.com
1 stats.g.doubleclick.net 1 redirects
1 js.adsrvr.org www.googletagmanager.com
1 sp.sitomobile.com www.empr.com
1 d31qbv1cthcecs.cloudfront.net www.empr.com
1 accounts.haymarketmedia.com 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
1 mpct1.maropost.com content.maropost.com
1 script.crazyegg.com www.googletagmanager.com
1 adservice.google.com www.googletagservices.com
1 adservice.google.de www.googletagservices.com
1 content.maropost.com www.empr.com
1 www.googletagmanager.com www.empr.com
1 tags.crwdcntrl.net www.empr.com
1 link.email.empr.com 1 redirects
242 53
Subject Issuer Validity Valid
*.empr.com
RapidSSL RSA CA 2018		 2019-01-16 -
2021-01-15		 2 years crt.sh
*.netdna-ssl.com
Sectigo RSA Domain Validation Secure Server CA		 2019-02-18 -
2020-02-27		 a year crt.sh
*.googleapis.com
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
tags.crwdcntrl.net
DigiCert SHA2 Secure Server CA		 2019-03-15 -
2021-04-07		 2 years crt.sh
*.g.doubleclick.net
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
s3.amazonaws.com
DigiCert Baltimore CA-2 G2		 2018-12-03 -
2019-10-25		 a year crt.sh
*.google-analytics.com
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
content.maropost.com
Amazon		 2018-10-25 -
2019-11-25		 a year crt.sh
*.google.com
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
ssl945600.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2		 2019-08-20 -
2020-02-26		 6 months crt.sh
*.scorecardresearch.com
COMODO RSA Organization Validation Secure Server CA		 2018-11-28 -
2019-12-26		 a year crt.sh
*.maropost.com
Go Daddy Secure Certificate Authority - G2		 2019-06-10 -
2021-08-09		 2 years crt.sh
ssl379818.cloudflaressl.com
COMODO ECC Domain Validation Secure Server CA 2		 2019-07-26 -
2020-02-01		 6 months crt.sh
accounts.haymarketmedia.com
Amazon		 2018-10-26 -
2019-11-26		 a year crt.sh
*.cloudfront.net
DigiCert Global CA G2		 2019-07-17 -
2020-07-05		 a year crt.sh
*.facebook.com
DigiCert SHA2 High Assurance Server CA		 2019-08-24 -
2019-10-19		 2 months crt.sh
*.sitomobile.com
RapidSSL RSA CA 2018		 2018-01-22 -
2020-07-29		 3 years crt.sh
*.adsrvr.org
Trustwave Organization Validation SHA256 CA, Level 1		 2019-03-07 -
2021-04-19		 2 years crt.sh
medtargetsystem.com
Amazon		 2018-11-23 -
2019-12-23		 a year crt.sh
*.ml314.com
Amazon		 2019-03-16 -
2020-04-16		 a year crt.sh
www.google.de
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
certify.alexametrics.com
Amazon		 2019-07-26 -
2020-08-26		 a year crt.sh
*.eyeota.net
Let's Encrypt Authority X3		 2019-07-11 -
2019-10-09		 3 months crt.sh
*.lytics.io
RapidSSL TLS RSA CA G1		 2018-01-26 -
2020-01-06		 2 years crt.sh
subapi.haymarketmedia.com
Amazon		 2019-06-28 -
2020-07-28		 a year crt.sh
*.medicalbag.com
RapidSSL RSA CA 2018		 2019-02-22 -
2020-02-22		 a year crt.sh
*.spotible.com
Go Daddy Secure Certificate Authority - G2		 2016-10-16 -
2019-11-06		 3 years crt.sh
adtrackapi.haymarketmedia.com
Amazon		 2019-03-27 -
2020-04-27		 a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2		 2019-06-13 -
2021-06-28		 2 years crt.sh
*.b2c.com
Amazon		 2019-03-24 -
2020-04-24		 a year crt.sh
tpc.googlesyndication.com
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh
www.google.com
GTS CA 1O1		 2019-08-23 -
2019-11-21		 3 months crt.sh

This page contains 11 frames:

Primary Page: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Frame ID: 52C826DFD5C6D6D9A90F90075AD43F1C
Requests: 207 HTTP requests in this frame

Frame: https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/1b8b3958c6e84842b6c08f6862b387a5?segments=true&mergestate=true&ts=1567914660049
Frame ID: 0A2C9D6382040A5557EAF35201EABED6
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 605FCC40B262310BE14657D4401239F1
Requests: 1 HTTP requests in this frame

Frame: https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F&_sid=3d4294db-87ee-4229-bc33-7532747fbd17&_vid=35d939d2-3d95-4ff6-bfd1-e4e8023a3c29&_ak=35-212-8F62AC13&_flash=false&_th=1567914659|1567914659|1
Frame ID: 59072A3C9A8B45A799D2887DE8272694
Requests: 1 HTTP requests in this frame

Frame: https://www.facebook.com/tr/
Frame ID: 108C4B88CD1E3D3EA2AD03E921DBAD27
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 3866F1FB3D0C0A292271DACC39DBCAC0
Requests: 2 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/c=14413/rand=618027801/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20drugs-in-the-pipeline/int=%23OpR%2397493%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20drugs-in-the-pipeline%20%3A%20twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/med=%23OpR%2397539%23Article%20Tags%20%3A%20Cardiovascular%20Disease%2CHyperlipoproteinemias/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933%22%7D/rt=ifr
Frame ID: A38444E550ED050A75C6A0BBBA4CA38D
Requests: 1 HTTP requests in this frame

Frame: https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&upid=7fhq4wn&upv=1.1.0
Frame ID: FF81DB27C611CD78AB1A1A35D85E1916
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvs--QFHpsbrLinbuDMhwp_W6aOka84y93wfJEuz1R21gFQO1gz449rxP7IGO9Yg1o1kqzlYbBXYWRUIfyuRJTHqeo3rVPo97LW_yF8N5Nn6w52nTj5ghPSqrNpnh9Gq3urdAt2MuvNjiPHXYWpdEbueKcbQoitXidFuJoiZ1K6Rfdca7euvD8_rcP0D2lwOMpgpbAK3FCiu6NLczr1SQ5W8xS6Ql7jwOGB9f4ms4tH46d2iDYJ2vxQabUoIIySQRwG3zTIHOCmCXSAdGTMNC0Dn6sfDm6KwXO6JfihE4Vv2EES_hY2TTdX&sig=Cg0ArKJSzHPe36Ukn4TCEAE&adurl=
Frame ID: B0D5046442660D1F365DB02F1FFAFBE1
Requests: 12 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssObCNQYWtPygyRfH7PBknr3dFC3NGJn-hFE3C9J5xrb7WqvIKUH3KKkzt2k2nmNIAMs8Qi5TelmYT9h1z-m6CCrDq5BHrzy6gREYfha1YJ8I03uSh3TVerVxG6njVk16TR1n1Lo86mzKvU6R2cdxwN79Qa4lTvbA0iNfFfJKqmiKqUTPXHTArQYmv-o7mh4j5hN05zJSORQZGjKsRYwx4q7dGGPRrIvNNySyvc2hjaZDPRcznV3Q6iGo0Jl1gmBovXrxT21Yku5jvjz3MHpFUAlOch-WwkQsceqcwEXQ&sig=Cg0ArKJSzOg_r9DclypLEAE&adurl=
Frame ID: C8FB884E0776A2A0EAB005197B7F7B69
Requests: 11 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/error_handler.js
Frame ID: 35A2704D0676AF0E7D1DE8294FFA93C2
Requests: 12 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. http://link.email.empr.com/a/1323/click/67302/5059933/26045578ac672cf0043e394ea957a021b8adcff9/4450e63a... HTTP 302
    https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-ef... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i
Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i
Overall confidence: 100%
Detected patterns
  • headers link /rel="https:\/\/api\.w\.org\/"/i
Overall confidence: 100%
Detected patterns
  • headers server /nginx(?:\/([\d.]+))?/i
Overall confidence: 100%
Detected patterns
  • script /script\.crazyegg\.com\/pages\/scripts\/\d+\/\d+\.js/i
Overall confidence: 100%
Detected patterns
  • script /\/\/connect\.facebook\.net\/[^\/]*\/[a-z]*\.js/i
Overall confidence: 100%
Detected patterns
  • script /google-analytics\.com\/(?:ga|urchin|analytics)\.js/i
Overall confidence: 100%
Detected patterns
  • html /googletagmanager\.com\/ns\.html[^>]+><\/iframe>/i
  • html /<!-- (?:End )?Google Tag Manager -->/i

Page Statistics

242
Requests

100 %
HTTPS

38 %
IPv6

34
Domains

53
Subdomains

47
IPs

7
Countries

5904 kB
Transfer

8296 kB
Size

40
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. http://link.email.empr.com/a/1323/click/67302/5059933/26045578ac672cf0043e394ea957a021b8adcff9/4450e63aa15b338fb174a6c27fc8d6b86cc81a99&amp HTTP 302
    https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 39
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&c9= HTTP 302
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&c9=
Request Chain 57
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12 HTTP 302
  • https://mt.sitomobile.com/sync/tacb?exid=df208181-d1eb-11e9-bd6d-3eb1b3ece342&aid=136&sid=hmm&val=12 HTTP 302
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Request Chain 63
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1377465944&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&ul=en-us&de=UTF-8&dt=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&_u=aGDAAAAjQ~&jid=927647139&gjid=588218430&cid=1173771773.1567914660&tid=UA-1290429-2&_gid=1002369859.1567914660&_r=1&gtm=2wg8l25XFK9V6&cd1=123438%3A0&cd2=cardiovascular%20disease%2Chyperlipoproteinemias&cd3=&cd4=&cd5=post&cd6=&cd7=home&cd8=news&cd9=drugs%20in%20the%20pipeline&cd10=twice-yearly%20cholesterol-lowering%20therapy%20effective%20in%20phase%203%20trial&cd11=omn&cd12=13&cd14=false&cd15=&cd16=false&cd17=&cd18=0&cd19=&cd31=&cd32=&cd33=&cd34=Brian%20Park%2C%20PharmD&cd35=MPR%20Drug%20News&cd36=&cd37=undefined&cd38=undefined&cd39=undefined&cd40=&cd41=&cd42=&cd43=&cd46=&cd48=&cd50=&cd52=&cd53=home&cd54=&cd55=&cd56=9&cd57=&cd58=&cd62=false&cd63=2019-09-06&cd64=368&cd67=&cd68=undef&cd71=false&cd78=false&cd79=false&cd80=false&cd93=drugs%20in%20the%20pipeline&z=1327517544 HTTP 302
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_gid=1002369859.1567914660&gjid=588218430&_v=j79&z=1327517544 HTTP 302
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544 HTTP 302
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544&slf_rd=1&random=2743159519
Request Chain 72
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151495441525110&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151495441525110%26eid=50056 HTTP 302
  • https://ml314.com/csync.ashx?fp=bqk81Q9999Yiv7H5&person_id=5978151495441525110&eid=50056
Request Chain 73
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151495441525110 HTTP 307
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5NTQ0MTUyNTExMBAAGg0IpPXR6wUSBQjoBxAAQgBKAA HTTP 307
  • https://ml314.com/csync.ashx?fp=ad161325fd6e8fce80d2b4d133c3f98c65721ddefa0668b24f00fb28bc33ae3af4cb09cee1a4f8eb&person_id=5978151495441525110&eid=50082
Request Chain 74
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151495441525110%26eid=50220 HTTP 302
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151495441525110%26eid=50220&mm_bnc&mm_bct&UUID=c3af5d74-71ee-4f00-8491-a9995531260b HTTP 302
  • https://ml314.com/csync.ashx?fp=c3af5d74-71ee-4f00-8491-a9995531260b&person_id=5978151495441525110&eid=50220
Request Chain 75
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151495441525110 HTTP 302
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151495441525110 HTTP 302
  • https://ml314.com/csync.ashx?fp=b77d9ea389e1e4a3e981fa427341876f&eid=50146&person_id=5978151495441525110
Request Chain 76
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif HTTP 302
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif HTTP 302
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2BWOnzFUaQZAEMqfXQAli9I7H2airaA5Z1sIfld2p3Z8&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil HTTP 302
  • https://ml314.com/csync.ashx?fp=2BWOnzFUaQZAEMqfXQAli9I7H2airaA5Z1sIfld2p3Z8&person_id=5978151495441525110&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil HTTP 302
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Request Chain 233
  • https://api-52-13-54-247.b2c.com/api/x?WHjlZadNwGfgCYL3$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 HTTP 302
  • https://api-52-13-54-247.b2c.com:444/api/4?WHjlZadNwGfgCYL3
Request Chain 236
  • https://api-54-185-17-100.b2c.com/api/x?N0OC5fhexkh01EES$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 HTTP 302
  • https://api-54-185-17-100.b2c.com:444/api/4?N0OC5fhexkh01EES
Request Chain 238
  • https://api-34-220-54-177.b2c.com/api/x?WWoJ47WuUZmunRpx$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 HTTP 302
  • https://api-34-220-54-177.b2c.com:444/api/4?WWoJ47WuUZmunRpx
Request Chain 239
  • https://api-35-164-230-125.b2c.com/api/x?VvXUIDQnkRauUX0a$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS90d2ljZS15ZWFybHktY2hvbGVzdGVyb2wtbG93ZXJpbmctdGhlcmFweS1lZmZlY3RpdmUtaW4tcGhhc2UtMy10cmlhbC8_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 HTTP 302
  • https://api-35-164-230-125.b2c.com:444/api/4?VvXUIDQnkRauUX0a

242 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
Primary Request /
www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/
Redirect Chain
  • http://link.email.empr.com/a/1323/click/67302/5059933/26045578ac672cf0043e394ea957a021b8adcff9/4450e63aa15b338fb174a6c27fc8d6b86cc81a99&amp
  • https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-2019...
101 KB
22 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
88458fe1cf6b8bbad56e744aef0a89de09782058f49b9cdb2de5cfb3f91e90a5

Request headers

:method
GET
:authority
www.empr.com
:scheme
https
:path
/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
none
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

status
200
server
nginx
date
Sun, 08 Sep 2019 03:50:59 GMT
content-type
text/html; charset=UTF-8
vary
Accept-Encoding Accept-Encoding Accept-Encoding,Cookie,X-WPENGINE-SEGMENT
x-distributor
yes
x-pingback
https://www.empr.com/xmlrpc.php
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/" <https://www.empr.com/?p=123438>; rel=shortlink
wpe-backend
apache
x-cacheable
SHORT
cache-control
max-age=600, must-revalidate
x-cache
HIT: 1
x-pass-why
x-cache-group
normal
x-wpengine-segment
NONHT
content-encoding
gzip

Redirect headers

Content-Type
text/html; charset=utf-8
Transfer-Encoding
chunked
Connection
keep-alive
Status
302 Found
Cache-Control
no-cache
X-XSS-Protection
1; mode=block
X-Request-Id
53be2b4e-a420-4768-9e13-0f4a927303ee
Location
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
X-Runtime
0.056183
X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
Date
Sun, 08 Sep 2019 03:50:58 GMT
Set-Cookie
_session_id=21345f7fda7c29aabe2e703ea935ece4; path=/; expires=Sun, 08 Sep 2019 15:50:58 -0000; HttpOnly
X-Powered-By
Phusion Passenger 5.3.4
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/ 		29 KB
5 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/css/dist/block-library/style.min.css?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
4b8fe5c3d0e5ef7a6582185cbf5c535b5d369c8df1da98c03ed69833e55f474d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Mon, 22 Apr 2019 12:40:04 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cbdb624-726f"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
shared-style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 		48 KB
7 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/shared-style.min.css?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
33fe4fe8214760f15a5fdd753b5c396ee5b916e5d6f66f79d4765ed260706723

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-c05a"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
style.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 		240 KB
32 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f1e3884dae2f0ddd32795c0c1ac83e9f9a8c7dce35dbd784bdc3c9872196bb1c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-3bfb4"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/ 		8 KB
814 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
bb4c48e63332f312f4d1945747e9e319247d26592eec54e38fe75eff833eb130
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sun, 08 Sep 2019 03:50:59 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sun, 08 Sep 2019 03:50:59 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
lytics.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/ 		39 KB
3 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/lytics.min.css?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6944e75951f2e7bf00121eea502e7d952a833e811e13a1f28fb077df6af721f3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-9de9"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
css
fonts.googleapis.com/ 		825 B
671 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://fonts.googleapis.com/css?family=Bree+Serif&ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
19aa6c614f72f6bb67cb17a6169ca551686c2bab5475293c95880f5f32cd830e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sun, 08 Sep 2019 03:50:59 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sun, 08 Sep 2019 03:50:59 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
autosuggest.min.css
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/ 		766 B
580 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/css/autosuggest.min.css?ver=3.0.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8689484e31c0c85e3e074f0b59348974f5de4b2eec412e388e2ea32924a41478

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-2fe"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
text/css
access-control-allow-origin
*
cache-control
public, max-age=2592000
jquery.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/ 		95 KB
34 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
1db21d816296e6939ba1f42962496e4134ae2b0081e26970864c40c6d02bb1df

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Fri, 17 May 2019 17:08:53 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5cdeeaa5-17a69"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
jquery-migrate.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/ 		10 KB
4 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
48eb8b500ae6a38617b5738d2b3faec481922a7782246e31d2755c034a45cd5d

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Fri, 20 May 2016 06:11:28 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"573eaa90-2748"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cookie.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/ 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/mu-plugins/cookie-controller/js/cookie.min.js?ver=1.2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
e828282e92509efc0f7bc57888382c5816bd403e0abbb685eda5c4372cc7daa5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-834"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
cc.js
tags.crwdcntrl.net/c/14413/ 		38 KB
11 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
93.184.220.113 London, United Kingdom, ASN15133 (EDGECAST - MCI Communications Services, Inc. d/b/a Verizon Business, US),
Reverse DNS
Software
ECS (fcn/40E9) /
Resource Hash
3c0c418574419249b3fff12c4cdb9a2ad6ddc191fa025ea56d4027552487e78c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 13 Aug 2019 19:05:38 GMT
server
ECS (fcn/40E9)
etag
"5d530a02-98ef+gzip"
vary
Accept-Encoding
x-cache
HIT
content-type
application/javascript
status
200
cache-control
max-age=86400
content-length
11304
expires
Mon, 09 Sep 2019 03:50:59 GMT
digest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 		16 KB
5 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/digest.min.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
b3c617e4ee00489d6fb85a53bd88cb1e1f5e71ae5244c54a7fea6b6e7d9921ad

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Wed, 22 May 2019 09:37:40 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5ce51864-3fc1"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
UtilityMove-custom.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/ 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
cffef365e4b53f1a6e9d33a7d42c0d1542b573360f774069589240f75f0e84f1

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-751"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
polyfill.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/ 		102 KB
35 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/js/frontend/polyfill.min.js?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
59173f786dd1f3802f7ab26fd339aac4099dc10c6cb54a6a92213e6af277592a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-19873"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
gpt.js
www.googletagservices.com/tag/js/ 		40 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
97a717fe2ce9e30c8d9cf1cd1f685449a6861139529e254a040df484dbb907ec
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"272 / 839 of 1000 / last-modified: 1567784465"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
12535
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
adtracking.js
s3.amazonaws.com/haymarket-adtracking-js/prod/ 		19 KB
19 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.115.21 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
822847109c3aaf484affe599900514bcf4167ceda17fcca7a97b691d780dae25

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Last-Modified
Tue, 15 Jan 2019 22:54:19 GMT
Server
AmazonS3
x-amz-request-id
C6CC53E58D308174
ETag
"dc289fc811d6d3a62b068bfcda1f8f30"
Content-Type
application/javascript
x-amz-version-id
MlU6AsBGwcOjZYgQIgNYntESpQyo9BbN
Accept-Ranges
bytes
Content-Length
19158
x-amz-id-2
ce6/4NsNDI2gMrvhDebF6iB6AMrX6fDqOOV+D1DqLskKWSsMn1c5SDuwy37Z6cYM+6AdXDfhWyY=
head.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 		43 KB
13 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/head.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
70c5977dcbb02566149a292768c9c22cd169b38e54d3275bfa29b5c7547905e9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-ac53"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
MPR-logo_website.png
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/ 		16 KB
16 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/MPR-logo_website.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
9c9401c3de840fa118289641c41b6125ca5825612d110a20584d2ba32036a1cf

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
etag
"452a9f099947d43a38734d72a92e9193"
last-modified
Wed, 20 Mar 2019 21:55:07 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
16492
expires
Fri, 20 Sep 2019 11:33:34 GMT
gtm.js
www.googletagmanager.com/ 		137 KB
34 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:819::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
ec203b51981bf6ce6eb507f5b88ce3e3a7fb89ad73f0469f13bc9a7ded72b9fd
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
br
last-modified
Sun, 08 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
34658
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
Park_Brian-150x150.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/ 		15 KB
15 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/05/Park_Brian-150x150.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
de709acbe98dba4f2f3fc3204a09a5add553a366b33501d54f78b5f263775785
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
etag
"5c39283ae49b2ce7914cb7d8d198c8a8"
last-modified
Tue, 20 Aug 2019 07:11:14 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14921
expires
Tue, 08 Oct 2019 03:50:18 GMT
ldlcholesterolss519309595_1389351.jpg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/ 		35 KB
35 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2018/12/ldlcholesterolss519309595_1389351.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3e9bdf053646485ec2c601475b7aab7946dbda6141a3c2842a4d06a24de120d4
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
etag
"c2e8ca5fdac208c50386c0a5013292b9"
last-modified
Wed, 20 Mar 2019 19:50:32 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-frame-options
SAMEORIGIN
x-cache
HIT
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
36015
expires
Sun, 06 Oct 2019 15:53:26 GMT
300x100mprsub-300x105.gif
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/ 		13 KB
14 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2019/01/300x100mprsub-300x105.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
f0341fe392815f4fedec6d94398334b176ce2fb0eafebc391a82afcb3cc5fef0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
etag
"fb86d90a5bcf340b8bd64802ec39a7a5"
last-modified
Wed, 20 Mar 2019 09:05:43 GMT
server
NetDNA-cache/2.2
x-amz-server-side-encryption
AES256
x-cache
HIT
content-type
image/gif
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
13667
expires
Fri, 20 Sep 2019 12:01:48 GMT
spinner.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/src/ 		694 B
630 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src/spinner.svg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
abb1dd7905b3797711e15609800d43cabead4c0358dc0030a1932a20e82a37d7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-2b6"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js
content.maropost.com/uploads/1323/websites/5/ 		3 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:b600:1b:fadc:b780:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
AmazonS3 /
Resource Hash
3b8eec5229515f9e95a68b635aba1d27d7d91f2e1b726302c53124fe18cefd20

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:34:35 GMT
via
1.1 89c822bb1ce1445a7be6d1057088cfbf.cloudfront.net (CloudFront)
last-modified
Thu, 27 Sep 2018 21:48:02 GMT
server
AmazonS3
age
985
etag
"ff4375eccda3ca6bc54ed96c5d77d9bb"
x-cache
Hit from cloudfront
status
200
x-amz-cf-pop
FRA6-C1
accept-ranges
bytes
content-length
2622
x-amz-cf-id
5rtMUtNaAVBK_pZZVqnbbXu9IVXsZROh4sfIwmSLSj35g4gKGZpjkA==
blocks.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 		7 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/blocks.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3ed3de3fd0fabc795d8b96ada205998944ff3157366f20b70d5d10b099b63120

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1b42"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
local-storage-lib.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 		1 KB
917 B 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/local-storage-lib.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
693d39f8b27d78f2a570672b862512cb8e3dee72e8f641cf95ada2d81bac720b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Wed, 17 Jul 2019 13:03:16 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d2f1c94-591"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
npi-manager.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/ 		3 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/hm-npi-manager/js/npi-manager.js?ver=2.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
43a5ba666207ae3718ce7fe6b4015c58043b4ac4dfdacae285d5d8574d80fdf6

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-b3b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
hmi-registration-ui.manifest.js
s3.amazonaws.com/haymarket-reg-js/develop/production/ 		799 B
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.manifest.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.115.21 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4d3e9dbf75d761b4fc344b3be601971eb517ce533c7ce46e093539e03349616e

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
80B2F0CBBA3DD229
ETag
"6878a8fbe72bde4a3f8ecf5b16523972"
Content-Type
application/javascript
x-amz-version-id
csLBKnYjTffo31CifRF6x383B2E_amuJ
Accept-Ranges
bytes
Content-Length
799
x-amz-id-2
lBh9odsr4zL57NxkUFbz7C5MmjtNm7CPUzqa1HS0xMb1OX1BO9C6LaPs2qouYTF3pFyjmJbz4Bw=
hmi-registration-ui.vendor.js
s3.amazonaws.com/haymarket-reg-js/develop/production/ 		357 KB
357 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.115.21 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
2673f6b0416b9a9f7488ee96f384f5badfa04acb14499c92ae52e394b7572f1f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
CB176E701A093290
ETag
"dfdfd93abc9eec4ff346a12a61df7c41"
Content-Type
application/javascript
x-amz-version-id
6ACuZZ4Fakkhaw3IL9mD952B0XZGZK4Q
Accept-Ranges
bytes
Content-Length
365119
x-amz-id-2
T9eT6gcSY7i0ANYUK9rEUf0ukYgUSr9lb2vn9enEzQCVQwuUdWhxqS36fbXSJeBGYVFm8TxoA2I=
hmi-registration-ui.bundle.js
s3.amazonaws.com/haymarket-reg-js/develop/production/ 		1 MB
1 MB 		Script
General
Check archive.org
Download Go to
Full URL
https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.216.115.21 Ashburn, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
s3-1.amazonaws.com
Software
AmazonS3 /
Resource Hash
4eef9cbbcb01ac2538e54c45514c0560e686abf17070adfba489fd1b3b86455a

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Last-Modified
Thu, 29 Aug 2019 20:10:10 GMT
Server
AmazonS3
x-amz-request-id
191B09D10E081BA9
ETag
"8f47379688c3f5980d42b891fcaea0eb"
Content-Type
application/javascript
x-amz-version-id
1g9qbXhjK6v_p1EyiVTzg_c7stFBXUFD
Accept-Ranges
bytes
Content-Length
1225121
x-amz-id-2
75Vg1zg9wqAmM5jhC2Nx5RjtsypnRLwu7VNH3JrfJg9GexCWIeSnxzgfaOMXJnhGhu2K8WLGLsc=
autosuggest.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/plugins/elasticpress/dist/js/autosuggest.min.js?ver=3.0.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
c93e697d8038c51fe0e5002d6ff046cfe3497e03a47c302684292b3f1eeb6c46

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Wed, 10 Jul 2019 08:59:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d25a8ee-117d"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
frontend.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 		147 KB
39 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
3b5a3ea636e4cd5a2bf556bff258470249c0267744de25cd28f173354ffe0239

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-24c7e"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
iab.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/ 		8 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
6463301e10c71f76fc14bb977dfa9097b5633ed4a3ee4119abccf2ead9aa9e29

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 29 Aug 2019 13:28:17 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5d67d2f1-1ecd"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
wp-embed.min.js
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/ 		1 KB
1003 B 		Script
General
Check archive.org
Download Go to
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/wp-embed.min.js?ver=5.2.3
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
2152557cac69e2bd7d6debef5037a9f554f9209cc305b8141b3329acb10c42b7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Thu, 30 Aug 2018 12:40:26 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5b87e5ba-57b"
vary
Accept-Encoding, Accept-Encoding
x-cache
HIT
content-type
application/javascript
access-control-allow-origin
*
cache-control
public, max-age=2592000
integrator.js
adservice.google.de/adsid/ 		109 B
476 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
integrator.js
adservice.google.com/adsid/ 		109 B
476 B 		Script
General
Check archive.org
Download Go to
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.empr.com
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
0482a98d09daebc18a0d2e1ed8f748da5b0179e61223ed541101df1f4699f073
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status
200
cache-control
private, no-cache, no-store
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
104
x-xss-protection
0
pubads_impl_2019082901.js
securepubads.g.doubleclick.net/gpt/ 		158 KB
59 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
sffe /
Resource Hash
ec6c461b6a7da1d28c5bb10b93c755c080ccdaed59821bdf1076bdc3866cc956
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 29 Aug 2019 13:06:32 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
59716
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
7341.js
script.crazyegg.com/pages/scripts/0034/ 		88 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://script.crazyegg.com/pages/scripts/0034/7341.js?435531
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9408 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
d536c04a27b4d59636b238893e67ed41e9b7546891a84c0c95da62b5cffaa2cc

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
via
1.1 8e04f5d6c745b231c10fce7c2aa9c70f.cloudfront.net (CloudFront)
cf-cache-status
HIT
age
41
cf-polished
origSize=90279
x-cache
Miss from cloudfront
status
200
content-encoding
gzip
last-modified
Thu, 05 Sep 2019 20:27:09 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/x-javascript
cache-control
private, max-age=300
x-amz-cf-pop
FRA6-C1
cf-ray
512df61f79c4cbb8-VIE
x-amz-cf-id
G_4Ict6Y3N_Dd_imy9A7ILt38DpJoUSdtLYgw-I1HyNmPyRZRGdv_A==
cf-bgj
minify
analytics.js
www.google-analytics.com/ 		43 KB
18 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
4046
date
Sun, 08 Sep 2019 02:43:33 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
17803
expires
Sun, 08 Sep 2019 04:43:33 GMT
b2
sb.scorecardresearch.com/
Redirect Chain
  • https://sb.scorecardresearch.com/b?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2Fw...
  • https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2F...
0
248 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&c9=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.214.103 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-111-214-103.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:50:59 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT

Redirect headers

Location
https://sb.scorecardresearch.com/b2?c1=2&c2=21948019&ns__t=1567914659423&ns_c=UTF-8&c8=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&c7=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&c9=
Pragma
no-cache
Date
Sun, 08 Sep 2019 03:50:59 GMT
Cache-Control
private, no-cache, no-cache=Set-Cookie, no-store, proxy-revalidate
Connection
keep-alive
Content-Length
0
Expires
Mon, 01 Jan 1990 00:00:00 GMT
src.svg
www.empr.com/wp-content/themes/haymarket/assets/svg/ 		33 KB
10 KB 		Other
General
Check archive.org
Download Go to
Full URL
https://www.empr.com/wp-content/themes/haymarket/assets/svg/src.svg?ver=1553589230
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
866e74600600f8647c979414828f3538d646101dc8504de84c2ed00e30460811

Request headers

Sec-Fetch-Mode
same-origin
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
nginx
status
200
etag
W/"5c99e3ee-8317"
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
S6uyw4BMUTPHjx4wXiWtFCc.woff2
fonts.gstatic.com/s/lato/v16/ 		14 KB
14 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wXiWtFCc.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
036d841b132c14046e26d8f2da1bc634c6ad34885ed1295660694a91c98933a6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 23 Aug 2019 19:26:23 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:55 GMT
server
sffe
age
1326276
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14044
x-xss-protection
0
expires
Sat, 22 Aug 2020 19:26:23 GMT
chevron-right-white.svg
1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/ 		190 B
399 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/svg/src/chevron-right-white.svg
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
94.31.29.64 , United Kingdom, ASN33438 (HIGHWINDS2 - Highwinds Network Group, Inc., US),
Reverse DNS
94.31.29.64.IPYX-077437-ZYO.above.net
Software
NetDNA-cache/2.2 /
Resource Hash
8e0da2e2d764c1a202d33dd39287784df8ac6bc20c7401ea14f2d62001292856

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/css/style.min.css?ver=1567085297
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
last-modified
Tue, 26 Mar 2019 08:33:50 GMT
server
NetDNA-cache/2.2
status
200
etag
W/"5c99e3ee-be"
vary
Accept-Encoding
x-cache
HIT
content-type
image/svg+xml
access-control-allow-origin
*
cache-control
public, max-age=2592000
BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
fonts.gstatic.com/s/robotoslab/v9/ 		11 KB
11 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngRUXZYTXPIvIBgJJSb6u92w7CGwR2oefDo.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4901c9453014d8e210b2f62189f68c2d7964543517e1fc8447924de7d542058a
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 23 Aug 2019 19:11:42 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:27:03 GMT
server
sffe
age
1327157
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11388
x-xss-protection
0
expires
Sat, 22 Aug 2020 19:11:42 GMT
BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
fonts.gstatic.com/s/robotoslab/v9/ 		11 KB
11 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/robotoslab/v9/BngMUXZYTXPIvIBgJJSb6ufN5qWr4xCC.woff2
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/assets/vendor/UtilityMove-custom.min.js?ver=1553589230
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
c68d891f07355e5d0807b4a4f18ac8f16f6e9088277be3134c7efa570022ab2d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 19:34:53 GMT
x-content-type-options
nosniff
last-modified
Mon, 22 Jul 2019 19:19:23 GMT
server
sffe
age
375366
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
11272
x-xss-protection
0
expires
Wed, 02 Sep 2020 19:34:53 GMT
S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
fonts.gstatic.com/s/lato/v16/ 		14 KB
14 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh6UVSwiPGQ3q5d0.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
9baad10e85c5be8d5697086479983b6b477197103bf8f0f11817b1bdfb9a7451
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 19:34:39 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:54 GMT
server
sffe
age
375380
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14176
x-xss-protection
0
expires
Wed, 02 Sep 2020 19:34:39 GMT
S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
fonts.gstatic.com/s/lato/v16/ 		15 KB
15 KB 		Font
General
Check archive.org
Download Go to
Full URL
https://fonts.gstatic.com/s/lato/v16/S6u8w4BMUTPHjxsAXC-qNiXg7Q.woff2
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fe4bbdad1d6dff75cde79f8afc07f29502bd4708cb0ce5f552083c3d81ba8382
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://fonts.googleapis.com/css?family=Lato:400,400i,700,700i|Roboto+Slab:400,400i,700,700i
Origin
https://www.empr.com
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 25 Aug 2019 03:27:53 GMT
x-content-type-options
nosniff
last-modified
Tue, 23 Jul 2019 03:45:51 GMT
server
sffe
age
1210986
status
200
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
14864
x-xss-protection
0
expires
Mon, 24 Aug 2020 03:27:53 GMT
js
www.google-analytics.com/gtm/ 		54 KB
21 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/gtm/js?id=GTM-T8P2ZZ9&t=gtm1&cid=1173771773.1567914660
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
ce031b46a6841c5d6125ff2cf3d3c5ccac4df64d4e3662f5b2815afe40c7530e
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
br
last-modified
Sun, 08 Sep 2019 03:00:00 GMT
server
Google Tag Manager
access-control-allow-headers
Cache-Control
status
200
vary
Accept-Encoding
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
http://www.googletagmanager.com
cache-control
private, max-age=900
access-control-allow-credentials
true
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
20805
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:50:59 GMT
96ac8580a54c3864c4ba15ff4a38efdcb7084985.js
mpct1.maropost.com/accounts/1323/websites/5/track/ 		4 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://mpct1.maropost.com/accounts/1323/websites/5/track/96ac8580a54c3864c4ba15ff4a38efdcb7084985.js?contact_id=5059933&campaign_id=67302&title=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&url=https%3A%2F%2Fempr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F&parent_url=&version=2&&&&funnel[0][name]=&funnel[0][status]=started&funnel[0][time_out]=40&
Requested by
Host: content.maropost.com
URL: https://content.maropost.com/uploads/1323/websites/5/96ac8580a54c3864c4ba15ff4a38efdcb7084985-v2.js?ver=1.1
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.238.92.4 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
4.92.238.35.bc.googleusercontent.com
Software
nginx/1.14.0 + Phusion Passenger 5.3.4 / Phusion Passenger 5.3.4
Resource Hash
5691524339d86f7a92156572e258ae069144fc9db208cdff3e5faa4ce04cceb4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
X-Powered-By
Phusion Passenger 5.3.4
Transfer-Encoding
chunked
Status
200 OK
Connection
keep-alive
Vary
Accept-Encoding
X-XSS-Protection
1; mode=block
X-Request-Id
71b4276c-413c-4c70-bee4-0a7b647bc282
X-Runtime
0.039865
Server
nginx/1.14.0 + Phusion Passenger 5.3.4
ETag
W/"31377a0293363f2ceba97d2755d29bd1"
X-Frame-Options
SAMEORIGIN
Content-Type
text/javascript; charset=utf-8
Cache-Control
max-age=0, private, must-revalidate
lio.js
c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/ 		45 KB
11 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
803e3ba42413340bcc0c185e1b5f40bfcc115ed3a52832ffcdf7827cbf239be0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df62019308c8c-VIE
date
Sun, 08 Sep 2019 03:50:59 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
5587
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sun, 08 Sep 2019 05:50:59 GMT
most-widget
www.empr.com/wp-json/haymarket/v1/ 		4 KB
2 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.empr.com/wp-json/haymarket/v1/most-widget?id=most-5
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d28b4ae6acb712afa381de4b558c9227595de9472d989d2d8666bd464580adb4
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 14
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
wpe-backend
apache
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
123438
www.empr.com/wp-json/haymarket/v1/infinite-scroll/ 		12 KB
3 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.empr.com/wp-json/haymarket/v1/infinite-scroll/123438
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
efc7808326b532c09cbb97190ced23fcced2ed3f9a2e6a473a742db0498eaf01
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
HIT: 1
status
200
x-wpengine-segment
NONHT
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
allow
GET
wpe-backend
apache
server
nginx
vary
Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie
content-type
application/json; charset=UTF-8
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
partial-login
www.empr.com/wp-json/haymarket/v1/ 		58 B
539 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.empr.com/wp-json/haymarket/v1/partial-login?subid=&subemail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d7b32b5c219a591a8d4c1b3fbf363951965e2d9917e66fda462d77cd4149e5cb
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-content-type-options
nosniff
x-cacheable
SHORT
x-cache
MISS
status
200
x-wpengine-segment
NONHT
vary
Accept-Encoding,Cookie
content-length
58
x-cache-group
normal
access-control-allow-headers
Authorization, Content-Type
wpe-backend
apache
server
nginx
allow
GET
content-type
application/json; charset=UTF-8
x-wpe-loopback-upstream-addr
127.0.0.1:6783
access-control-expose-headers
X-WP-Total, X-WP-TotalPages
cache-control
max-age=600, must-revalidate
x-distributor
yes
accept-ranges
bytes
x-robots-tag
noindex
link
<https://www.empr.com/wp-json/>; rel="https://api.w.org/"
x-pass-why
/
accounts.haymarketmedia.com/sso/check/ 		45 B
441 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://accounts.haymarketmedia.com/sso/check/?gn=101
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.174.96.0 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-174-96-0.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
916b46685de3064525220ba828d946e60ab332f5e65c62d7df5fe9877f9c54b2

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-aspnetmvc-version
4.0
server
Microsoft-IIS/8.5
x-aspnet-version
4.0.30319
x-powered-by
ASP.NET
status
200
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.empr.com
cache-control
private
access-control-allow-credentials
true
content-length
45
atrk.js
d31qbv1cthcecs.cloudfront.net/ 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://d31qbv1cthcecs.cloudfront.net/atrk.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.37 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-37.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
90451ba3e82cd9db02f0ca76bd45d0ab5ef7e90a49da4215903cb7f08471e2e7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Wed, 10 Jul 2019 17:30:33 GMT
Content-Encoding
gzip
Connection
keep-alive
Last-Modified
Sat, 16 Mar 2019 16:01:33 GMT
Server
AmazonS3
Age
5134827
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
text/javascript
Via
1.1 2d1e1e8dc0f3eb7773ec9d89a7d50ce2.cloudfront.net (CloudFront)
Cache-Control
max-age=26920000
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
BQP54UHDEcs-f4ZanlhnQsVOBtQfRhAGs72YUASHbUncTHJKiaODaQ==
gg.js
sb.scorecardresearch.com/rs/pt/ 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://sb.scorecardresearch.com/rs/pt/gg.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.214.103 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-111-214-103.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d0e90581c7b707bcad9f78f9b066371e6b1377d993ff03cbdee7193d6068ac78

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Content-Encoding
gzip
Connection
keep-alive
X-N
S
Content-Length
1246
Vary
Accept-Encoding
Content-Type
application/x-javascript
fbevents.js
connect.facebook.net/en_US/ 		121 KB
32 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/en_US/fbevents.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
14d88b3a27f0e6de034f86ad42d6411081e9467daf754147f2f16bcb20782177
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
31604
x-xss-protection
0
pragma
public
x-fb-debug
T8dB2LK+9CDbmik0QADdJh0vrpW2iFQKkO3yPEWqnUklml4DlFRWoEcDpxQictu1heHSa7pCGl5Ni5fpvWvQgg==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sun, 08 Sep 2019 03:50:59 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self';
expires
Sat, 01 Jan 2000 00:00:00 GMT
i
sp.sitomobile.com/
Redirect Chain
  • https://mt.sitomobile.com/sync/ta?aid=136&sid=hmm&val=12
  • https://pixel.tapad.com/idsync/ex/push?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://pixel.tapad.com/idsync/ex/push/check?partner_id=2822&partner_url=https%3A%2F%2Fmt.sitomobile.com%2Fsync%2Ftacb%3Fexid%3D%24%7BTA_DEVICE_ID%7D%26aid%3D136%26sid%3Dhmm%26val%3D12
  • https://mt.sitomobile.com/sync/tacb?exid=df208181-d1eb-11e9-bd6d-3eb1b3ece342&aid=136&sid=hmm&val=12
  • https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5...
43 B
388 B 		Script
General
Check archive.org
Download Go to
Full URL
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.225.65.223 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-225-65-223.compute-1.amazonaws.com
Software
Apache-Coyote/1.1 /
Resource Hash
f4eef8263281c0b26486637831251059757bc3fdc4c3a48045a8ef8646b36e8f

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Server
Apache-Coyote/1.1
Connection
keep-alive
P3P
policyref="/w3c/p3p.xml", CP="NOI DSP COR NID PSA OUR IND COM NAV STA"
Content-Length
43
Content-Type
image/gif

Redirect headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Server
nginx/1.12.1
X-Powered-By
Express
Vary
Accept
Content-Type
text/plain; charset=utf-8
Location
https://sp.sitomobile.com/i?tna=sito&p=mob&e=ue&ue_px=eyJzY2hlbWEiOiJpZ2x1OmNvbS5zbm93cGxvd2FuYWx5dGljcy5zbm93cGxvdy91bnN0cnVjdF9ldmVudC9qc29uc2NoZW1hLzEtMC0wIiwiZGF0YSI6eyJzY2hlbWEiOiJpZ2x1OmNvbS5zaXRvbW9iaWxlLnNub3dwbG93L2Nvb2tpZV9zeW5jL2pzb25zY2hlbWEvMS0wLTAiLCJkYXRhIjp7InBhcnRuZXJJZCI6InRhcGFkIn19fQ%3D%3D&cx=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
Connection
keep-alive
Content-Length
972
up_loader.1.1.0.js
js.adsrvr.org/ 		6 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://js.adsrvr.org/up_loader.1.1.0.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.207.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-207-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7e98e381189d908e1981b6e535bcdd7f3edceafdb0e7095f3e04292e8aac6a0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 07 Sep 2019 19:05:09 GMT
Content-Encoding
gzip
Last-Modified
Wed, 17 Jul 2019 18:26:10 GMT
Server
AmazonS3
Age
31710
Vary
Accept-Encoding
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 fc7091924e65025d5bfb92361ec3e660.cloudfront.net (CloudFront)
Connection
keep-alive
Transfer-Encoding
chunked
X-Amz-Cf-Pop
FRA53-C1
X-Amz-Cf-Id
QrhH7HGOmdJMcWLbdkGMA6GiKcZ00JEY4sAfzkYsbSlE5oBzK1Z-_A==
beacon.js
www.medtargetsystem.com/javascript/ 		176 KB
52 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) /
Resource Hash
96c02a809234415c196ffe1c2f4c0c87078ca7eaea213ebc7d8c9e5800c60764

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Content-Encoding
gzip
Last-Modified
Fri, 06 Sep 2019 19:17:45 GMT
Server
Apache/2.4.7 (Ubuntu)
ETag
"2c187-591e74afb2840-gzip"
Vary
X-Forwarded-Proto,Accept-Encoding
Content-Type
application/javascript
Connection
keep-alive
Accept-Ranges
bytes
Content-Length
52901
linkid.js
www.google-analytics.com/plugins/ua/ 		2 KB
995 B 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/plugins/ua/linkid.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
92fca55833f48b4289ac8f1cedd48752b580fce4ec4b5d81670b8193d6e51b54
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 02:59:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 21 Apr 2016 03:17:22 GMT
server
sffe
age
3104
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=3600
accept-ranges
bytes
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
856
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:59:15 GMT
analytics.js
www.google-analytics.com/ 		43 KB
17 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
dbb67c620eaabf6679a314db18d3ae43037aef71ab27422e6feec08ee987cc0a
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Mon, 19 Aug 2019 17:22:41 GMT
server
Golfe2
age
4046
date
Sun, 08 Sep 2019 02:43:33 GMT
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
public, max-age=7200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
17803
expires
Sun, 08 Sep 2019 04:43:33 GMT
tag.aspx
ml314.com/ 		26 KB
12 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ml314.com/tag.aspx?882019
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
390a28be2ca4bcea5b71fe050295281a1a8fc99175690cdd62de378190400acb

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Content-Encoding
gzip
Last-Modified
Sat, 07 Sep 2019 05:33:34 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=6154
Connection
keep-alive
Content-Length
11933
Expires
Sun, 08 Sep 2019 05:33:34 GMT
ga-audiences
www.google.de/ads/
Redirect Chain
  • https://www.google-analytics.com/r/collect?v=1&_v=j79&a=1377465944&t=pageview&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-ef...
  • https://stats.g.doubleclick.net/r/collect?v=1&aip=1&t=dc&_r=3&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_gid=1002369859.1567914660&gjid=588218430&_v=j79&z=1327517544
  • https://www.google.com/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544
  • https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544&slf_rd=1&random=2743159519
42 B
374 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544&slf_rd=1&random=2743159519
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81e::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:50:59 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
cache-control
no-cache, no-store, must-revalidate
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:50:59 GMT
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
302
content-type
text/html; charset=UTF-8
location
https://www.google.de/ads/ga-audiences?v=1&aip=1&t=sr&_r=4&tid=UA-1290429-2&cid=1173771773.1567914660&jid=927647139&_v=j79&z=1327517544&slf_rd=1&random=2743159519
cache-control
no-cache, no-store, must-revalidate
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
io.min.js
c.lytics.io/static/v2/ 		13 KB
6 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/static/v2/io.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
b2435070f04e40c2666a729a016c60355b2025c969c3b7857489b7c8b2755bc2

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df62049478c8c-VIE
date
Sun, 08 Sep 2019 03:50:59 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 26 Jun 2019 19:48:45 GMT
server
cloudflare
age
6490
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sun, 08 Sep 2019 05:50:59 GMT
1073716492693685
connect.facebook.net/signals/config/ 		307 KB
78 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/config/1073716492693685?v=2.9.4&r=stable
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
93c4a8cc5d4782ed85c9a7661ce68d1e7e7e6d4a91a57219f649f77564617460
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
79754
x-xss-protection
0
pragma
public
x-fb-debug
biXNBj0it3WfY6XpBLjjbGLt5u2GETwQR9vJ+uqxk/MsdrPtGngrT3ikk3/3vooeIWIjdfkWPuWKGsnJH4gLoQ==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sun, 08 Sep 2019 03:50:59 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
atrk.gif
certify.alexametrics.com/ 		43 B
553 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://certify.alexametrics.com/atrk.gif?frame_height=1200&frame_width=1600&iframe=0&title=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&time=1567914659883&time_zone_offset=-120&screen_params=1600x1200x24&java_enabled=0&cookie_enabled=1&ref_url=&host_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&random_number=17878659951&sess_cookie=9e84c6cf16d0eff102bfb635a9a&sess_cookie_flag=1&user_cookie=9e84c6cf16d0eff102bfb635a9a&user_cookie_flag=1&dynamic=true&domain=empr.com&account=gujPp1NErb205V&jsv=20130128&user_lang=en-US
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.113 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-113.fra53.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
89fe0ee6020314794fc2cfeacf3d10c31050cfe56f8ebddf1ed0a33fbe941fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sat, 07 Sep 2019 04:50:26 GMT
Via
1.1 f960fa0538fdb326fc338e984fa7ece9.cloudfront.net (CloudFront)
Last-Modified
Mon, 17 Jan 2011 20:41:40 GMT
Server
AmazonS3
Age
120802
ETag
"221d8352905f2c38b3cb2bd191d630b0"
X-Cache
Hit from cloudfront
Content-Type
image/gif
Connection
keep-alive
Accept-Ranges
bytes
X-Amz-Cf-Pop
FRA53-C1
x-amz-meta-alexa-last-modified
20110117123941
Content-Length
43
X-Amz-Cf-Id
BmnNxDATaRD5OGzdA4GG8pfiio1SR6I4eXgT9N7RrtIvuIZr5zMLWg==
4
c.lytics.io/cid/ 		77 B
353 B 		Script
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/cid/4?callback=jQuery112409934222591095923_1567914659291&_=1567914659292
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery.js?ver=1.12.4-wp
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
adb963cc7b684b982d6317c15b0d08257e7ad2362a7f5a0eef90a5bf04b4db05

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df620694f8c8c-VIE
pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
text/javascript
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
content-encoding
br
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
expires
0
inferredEvents.js
connect.facebook.net/signals/plugins/ 		35 KB
10 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://connect.facebook.net/signals/plugins/inferredEvents.js?v=2.9.4
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f02d:12:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
/
Resource Hash
b4e9e9bef19c34422f55a7fdb9d10c4db5e39cff24b8c98a0be0e09b2ee6ac2b
Security Headers
Name Value
Content-Security-Policy default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security max-age=31536000; preload; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options DENY
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000; preload; includeSubDomains
content-encoding
gzip
x-content-type-options
nosniff
status
200
content-length
10218
x-xss-protection
0
pragma
public
x-fb-debug
F56SYioFeqCqhA6/nVFhNKKmiYyPHn4Ib8llrdEn5S7czvmKiAzO6VktyYxlqzJtCg2A9WPP1/rrp4VjMWjN/Q==
x-fb-trip-id
420120009
x-frame-options
DENY
date
Sun, 08 Sep 2019 03:50:59 GMT
vary
Origin, Accept-Encoding
access-control-allow-methods
OPTIONS
content-type
application/x-javascript; charset=utf-8
access-control-allow-origin
https://connect.facebook.net
access-control-expose-headers
X-FB-Debug, X-Loader-Length
cache-control
public, max-age=1200
access-control-allow-credentials
true
content-security-policy
default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires
Sat, 01 Jan 2000 00:00:00 GMT
/
www.facebook.com/tr/ 		44 B
324 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.facebook.com/tr/?id=1073716492693685&ev=PageView&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&rl=&if=false&ts=1567914659918&sw=1600&sh=1200&v=2.9.4&r=stable&ec=0&o=30&fbp=fb.1.1567914659917.899085242&it=1567914659882&coo=false&rqm=GET
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:50:59 GMT
last-modified
Fri, 21 Dec 2012 00:00:01 GMT
server
proxygen-bolt
strict-transport-security
max-age=31536000; includeSubDomains
content-type
image/gif
status
200
cache-control
no-cache, must-revalidate, max-age=0
content-length
44
expires
Sun, 08 Sep 2019 03:50:59 GMT
utsync.ashx
ml314.com/ 		793 B
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=740&ct=js&pi=&fp=&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&pv=1567914659970_x0yckoqnp&bl=en-us&cb=5132898&return=&ht=&d=&dc=&si=1567914659970_x0yckoqnp&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?882019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
c89d4d354ab086cd17abd3c3892273e9be0d33b74dd683a2d4eea269d26765e3

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:50:59 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
private
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
485
Expires
0
ud.ashx
in.ml314.com/ 		20 B
698 B 		Script
General
Check archive.org
Download Go to
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=882019
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?882019
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.233.109.111 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-233-109-111.compute-1.amazonaws.com
Software
Microsoft-IIS/8.5 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/8.5
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, no-cache="set-cookie"
Connection
keep-alive
Content-Length
138
Expires
Mon, 09 Sep 2019 03:51:00 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://tags.bluekai.com/site/20486?limit=0&id=5978151495441525110&redir=https://ml314.com/csync.ashx%3Ffp=$_BK_UUID%26person_id=5978151495441525110%26eid=50056
  • https://ml314.com/csync.ashx?fp=bqk81Q9999Yiv7H5&person_id=5978151495441525110&eid=50056
43 B
312 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ml314.com/csync.ashx?fp=bqk81Q9999Yiv7H5&person_id=5978151495441525110&eid=50056
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 08 Sep 2019 23:51:00 GMT

Redirect headers

Location
https://ml314.com/csync.ashx?fp=bqk81Q9999Yiv7H5&person_id=5978151495441525110&eid=50056
Date
Sun, 08 Sep 2019 03:51:00 GMT
Connection
keep-alive
Content-Length
0
BK-Server
6507
P3P
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV", policyref="http://tags.bluekai.com/w3c/p3p.xml"
csync.ashx
ml314.com/
Redirect Chain
  • https://idsync.rlcdn.com/395886.gif?partner_uid=5978151495441525110
  • https://idsync.rlcdn.com/1000.gif?memo=CO6UGBIeChoIARCuXxoTNTk3ODE1MTQ5NTQ0MTUyNTExMBAAGg0IpPXR6wUSBQjoBxAAQgBKAA
  • https://ml314.com/csync.ashx?fp=ad161325fd6e8fce80d2b4d133c3f98c65721ddefa0668b24f00fb28bc33ae3af4cb09cee1a4f8eb&person_id=5978151495441525110&eid=50082
43 B
312 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ml314.com/csync.ashx?fp=ad161325fd6e8fce80d2b4d133c3f98c65721ddefa0668b24f00fb28bc33ae3af4cb09cee1a4f8eb&person_id=5978151495441525110&eid=50082
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 08 Sep 2019 23:51:00 GMT

Redirect headers

date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
status
307
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
location
https://ml314.com/csync.ashx?fp=ad161325fd6e8fce80d2b4d133c3f98c65721ddefa0668b24f00fb28bc33ae3af4cb09cee1a4f8eb&person_id=5978151495441525110&eid=50082
cache-control
no-cache, no-store
timing-allow-origin
*
alt-svc
clear
content-length
0
csync.ashx
ml314.com/
Redirect Chain
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151495441525110%26eid=50220
  • https://pixel.mathtag.com/sync/img?redir=https://ml314.com/csync.ashx%3Ffp=[MM_UUID]%26person_id=5978151495441525110%26eid=50220&mm_bnc&mm_bct&UUID=c3af5d74-71ee-4f00-8491-a9995531260b
  • https://ml314.com/csync.ashx?fp=c3af5d74-71ee-4f00-8491-a9995531260b&person_id=5978151495441525110&eid=50220
43 B
312 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ml314.com/csync.ashx?fp=c3af5d74-71ee-4f00-8491-a9995531260b&person_id=5978151495441525110&eid=50220
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 08 Sep 2019 23:51:00 GMT

Redirect headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Server
MT3 1684 2519bb0 master zrh-pixel-x11
P3P
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ml314.com/csync.ashx?fp=c3af5d74-71ee-4f00-8491-a9995531260b&person_id=5978151495441525110&eid=50220
Cache-Control
no-cache
Connection
keep-alive
Content-Type
image/gif
Content-Length
0
Expires
Sun, 08 Sep 2019 03:50:59 GMT
csync.ashx
ml314.com/
Redirect Chain
  • https://sync.crwdcntrl.net/map/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151495441525110
  • https://sync.crwdcntrl.net/map/ct=y/c=6985/tp=BOMB?https://ml314.com/csync.ashx%3Ffp%3D%24%7Bprofile_id%7D%26eid%3D50146%26person_id%3D5978151495441525110
  • https://ml314.com/csync.ashx?fp=b77d9ea389e1e4a3e981fa427341876f&eid=50146&person_id=5978151495441525110
43 B
312 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ml314.com/csync.ashx?fp=b77d9ea389e1e4a3e981fa427341876f&eid=50146&person_id=5978151495441525110
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.252.62.73 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-252-62-73.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
image/gif
Cache-Control
private
Connection
keep-alive
Content-Length
43
Expires
Sun, 08 Sep 2019 23:51:00 GMT

Redirect headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:00 GMT
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Location
https://ml314.com/csync.ashx?fp=b77d9ea389e1e4a3e981fa427341876f&eid=50146&person_id=5978151495441525110
Cache-Control
no-cache
X-Server
10.45.21.49
Connection
keep-alive
Content-Length
0
Expires
0
match
ps.eyeota.net/
Redirect Chain
  • https://ps.eyeota.net/pixel?pid=r8hrb20&t=gif
  • https://ps.eyeota.net/pixel/bounce/?pid=r8hrb20&t=gif
  • https://ml314.com/utsync.ashx?eid=50052&et=0&fp=2BWOnzFUaQZAEMqfXQAli9I7H2airaA5Z1sIfld2p3Z8&gdpr=1&gdpr_consent=&return=https%3A%2F%2Fps.eyeota.net%2Fmatch%3Fbid%3Dr8hrb20%26uid%3Dnil
  • https://ml314.com/csync.ashx?fp=2BWOnzFUaQZAEMqfXQAli9I7H2airaA5Z1sIfld2p3Z8&person_id=5978151495441525110&eid=50052&return=https%3a%2f%2fps.eyeota.net%2fmatch%3fbid%3dr8hrb20%26uid%3dnil
  • https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
70 B
171 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
18.195.52.121 Frankfurt am Main, Germany, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-18-195-52-121.eu-central-1.compute.amazonaws.com
Software
/
Resource Hash
de9d3fd0eb948bd294477d0eda60a73b85caff1794803530d0463193a113da98

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Content-Length
70
Content-Type
image/gif

Redirect headers

Date
Sun, 08 Sep 2019 03:50:59 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Content-Type
text/html; charset=utf-8
Location
https://ps.eyeota.net/match?bid=r8hrb20&uid=nil
Cache-Control
private
Connection
keep-alive
Content-Length
168
Expires
Sun, 08 Sep 2019 23:51:00 GMT
1b8b3958c6e84842b6c08f6862b387a5
api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/ Frame 0A2C 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://api.lytics.io/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/1b8b3958c6e84842b6c08f6862b387a5?segments=true&mergestate=true&ts=1567914660049
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io 910393fbafbb08c3ef4e7267ee4b5e65ce7f6385 /
Resource Hash

Request headers

:method
GET
:authority
api.lytics.io
:scheme
https
:path
/api/me/iframe/43bffbce6f25564c8e2145a11836ff9f/_uid/1b8b3958c6e84842b6c08f6862b387a5?segments=true&mergestate=true&ts=1567914660049
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
accept-encoding
gzip, deflate, br
cookie
__cfduid=db8c245f6c381df417b9ebe1e38936c5f1567914659; seerid=1b8b3958c6e84842b6c08f6862b387a5
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

status
200
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
access-control-allow-methods
GET
access-control-allow-origin
content-encoding
gzip
content-type
text/html
server
lytics.io 910393fbafbb08c3ef4e7267ee4b5e65ce7f6385
date
Sun, 08 Sep 2019 03:51:00 GMT
content-length
294
via
1.1 google
alt-svc
clear
css
fonts.googleapis.com/ 		1 KB
477 B 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://fonts.googleapis.com/css?family=Lato:400,900
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.bundle.js?ver=0.1.1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:809::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
ESF /
Resource Hash
4bd7ab38b940371c161b19f0cf34bdfdeaac480eda86b13c29591ed01ed67c36
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
br
last-modified
Sun, 08 Sep 2019 03:51:00 GMT
server
ESF
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
status
200
date
Sun, 08 Sep 2019 03:51:00 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:00 GMT
truncated
/ 		5 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
d9593473fc4d73446eac1a620bb1bbe590fc80d61d8909484dfee64ae522b787

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
13
subapi.haymarketmedia.com/newsletter/ 		3 KB
4 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
13
subapi.haymarketmedia.com/newsletter/ 		3 KB
4 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://subapi.haymarketmedia.com/newsletter/13
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
dc33184388cdcf8d8744da89db61d1633ff8219cc2a82f5c16758ff51a6ef531

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-powered-by
Express
etag
W/"d3e-V8fKzUWOVMxpQEouMHWsycPY5EQ"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/html; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
3390
truncated
/ 		24 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65f72bc49f7e243cf332df6eb265d987e4c6e997e7aecd813ceace591f805071

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/gif
truncated
/ 		82 KB
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ad9d820f1802abd0f80d4e260c43cd6c92d643c926732a00296821182ae3f9c7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml
/
www.facebook.com/tr/ Frame 605F 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
12743
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
accept-encoding
gzip, deflate, br
cookie
fr=0DlMNrO2XW3arFocq..BddHqj...1.0.BddHqj.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Sun, 08 Sep 2019 03:51:00 GMT
Cookie set /
www.medtargetsystem.com/beacon/portal/ Frame 5907 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.medtargetsystem.com/beacon/portal/?_url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F&_sid=3d4294db-87ee-4229-bc33-7532747fbd17&_vid=35d939d2-3d95-4ff6-bfd1-e4e8023a3c29&_ak=35-212-8F62AC13&_flash=false&_th=1567914659|1567914659|1
Requested by
Host: www.medtargetsystem.com
URL: https://www.medtargetsystem.com/javascript/beacon.js?v2.5.12
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash

Request headers

Host
www.medtargetsystem.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

Cache-Control
no-store, no-cache, must-revalidate
Content-Encoding
gzip
Content-Type
text/html; charset=UTF-8
Date
Sun, 08 Sep 2019 03:51:00 GMT
Expires
Thu, 19 Nov 1981 08:52:00 GMT
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Pragma
no-cache
Server
Apache/2.4.7 (Ubuntu)
Set-Cookie
DMDSESSID=48gevv5p7bjco29arrvgahdlo2; path=/; HttpOnly
Vary
X-Forwarded-Proto,Accept-Encoding
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
6989
Connection
keep-alive
collect.gif
www.medtargetsystem.com/analytics/ 		0
313 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.medtargetsystem.com/analytics/collect.gif?e=1&aid=&vid=35d939d2-3d95-4ff6-bfd1-e4e8023a3c29&sid=3d4294db-87ee-4229-bc33-7532747fbd17&vh=1&vt=1567914659&pt=1567914659&u=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&r=&t=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&p=1895.25&pm=&ab=&ak=35-212-8F62AC13
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.1.219.33 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-1-219-33.compute-1.amazonaws.com
Software
Apache/2.4.7 (Ubuntu) / PHP/7.0.19-1+deb.sury.org~trusty+2
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Server
Apache/2.4.7 (Ubuntu)
Connection
keep-alive
X-Powered-By
PHP/7.0.19-1+deb.sury.org~trusty+2
Content-Length
0
Vary
X-Forwarded-Proto
Content-Type
text/html; charset=UTF-8
/
www.facebook.com/tr/ Frame 108C 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.facebook.com/tr/
Requested by
Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a03:2880:f12d:83:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK - Facebook, Inc., US),
Reverse DNS
Software
proxygen-bolt /
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains

Request headers

:method
POST
:authority
www.facebook.com
:scheme
https
:path
/tr/
content-length
3702
pragma
no-cache
cache-control
no-cache
origin
https://www.empr.com
upgrade-insecure-requests
1
content-type
application/x-www-form-urlencoded
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
accept-encoding
gzip, deflate, br
cookie
fr=0DlMNrO2XW3arFocq..BddHqj...1.0.BddHqj.
Origin
https://www.empr.com
Upgrade-Insecure-Requests
1
Content-Type
application/x-www-form-urlencoded
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

status
200
content-type
text/plain
access-control-allow-origin
https://www.empr.com
access-control-allow-credentials
true
strict-transport-security
max-age=31536000; includeSubDomains
content-length
0
server
proxygen-bolt
date
Sun, 08 Sep 2019 03:51:00 GMT
pathfora.min.js
c.lytics.io/static/ 		98 KB
20 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/static/pathfora.min.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
4215e6200c04a4874f3d23c78af23fcd22b5bc3bc916237fd95c108aaae38735

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df6244a618c8c-VIE
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
5962
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sun, 08 Sep 2019 05:51:00 GMT
43bffbce6f25564c8e2145a11836ff9f
c.lytics.io/c/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f?_ts=1567914660497&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_e=pv&utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&_sesstart=1&_tz=2&_ul=en-US&_sz=1600x1200&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a638c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
104 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1567914659234&event=gtm.js&gtm.uniqueEventId=15&_ts=1567914660499&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a648c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.AdBlocking=&_ts=1567914660500&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a658c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NHTFlag=false&_ts=1567914660501&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a668c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleId=123438%3A0&_ts=1567914660501&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a678c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.ArticleType=MPR%20Drug%20News&_ts=1567914660502&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a688c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.MetaData=&_ts=1567914660502&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a698c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Type=post&_ts=1567914660502&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6a8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.ScrollDepth=&_ts=1567914660503&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6b8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.cmeActivityId=&_ts=1567914660503&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6c8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PrintSource=&_ts=1567914660503&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6d8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.SEOScore=&_ts=1567914660503&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6e8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.Prefix=omn&_ts=1567914660504&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a6f8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Site.PublicationId=13&_ts=1567914660504&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a718c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Author=Brian%20Park%2C%20PharmD&_ts=1567914660504&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a728c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.PremiumMonograph=&_ts=1567914660504&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a738c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.Geolocation=&_ts=1567914660504&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a748c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Activity.Name=&_ts=1567914660505&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a758c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GenericEvents=&_ts=1567914660505&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a778c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.CurrencyCode=&_ts=1567914660505&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a788c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.OrderId=&_ts=1567914660505&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a798c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Drug.CompanyName=&_ts=1567914660506&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a7a8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Novo.IsPremiumMonograph=false&_ts=1567914660506&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6245a7b8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.GatingType=post%3Anone&_ts=1567914660506&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a7d8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Company=&_ts=1567914660506&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a7e8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Discipline=&_ts=1567914660507&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a7f8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Asset=&_ts=1567914660507&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a808c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.PublishDate=2019-09-06&_ts=1567914660507&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a818c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.Curation=false&_ts=1567914660507&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a828c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Article.WordCount=368&_ts=1567914660508&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a838c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.CreditType=&_ts=1567914660508&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a848c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?MyCME.ActivityResult=&_ts=1567914660508&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a858c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.NumberofAdCalls=9&_ts=1567914660508&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a878c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?eComm.ProductsInCart=&_ts=1567914660508&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a888c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section1=home&_ts=1567914660509&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a898c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
101 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section2=home%3Anews&_ts=1567914660509&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8a8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section3=home%3Anews%3Adrugs%20in%20the%20pipeline&_ts=1567914660509&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8b8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Section4=home%3Anews%3Adrugs%20in%20the%20pipeline%3Atwice-yearly%20cholesterol-lowering%20therapy%20effective%20in%20phase%203%20trial&_ts=1567914660509&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8c8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Tags=cardiovascular%20disease%2Chyperlipoproteinemias&_ts=1567914660510&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8d8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?Page.Categories=drugs%20in%20the%20pipeline&_ts=1567914660510&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8e8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.LoggedIn=false&_ts=1567914660510&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a8f8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Login=&_ts=1567914660510&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a908c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
104 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SocSSN=&_ts=1567914660510&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a918c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
95 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SSO=0&_ts=1567914660511&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a928c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
95 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubscriberId=&_ts=1567914660511&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a948c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Source=&_ts=1567914660511&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a958c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
231 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Profession=&_ts=1567914660511&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a968c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Specialty=&_ts=1567914660512&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a978c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
101 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubProfession=&_ts=1567914660512&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a988c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.SubSpecialty=&_ts=1567914660512&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9a8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.JobTitle=&_ts=1567914660512&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9b8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
95 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CampaignCodes=im_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH&_ts=1567914660512&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9c8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Country=&_ts=1567914660513&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9d8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
119 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.Company=&_ts=1567914660513&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9e8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.CompanySize=&_ts=1567914660513&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246a9f8c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
95 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsHaymarket=false&_ts=1567914660513&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246aa08c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
166 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsTracked=false&_ts=1567914660514&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246aa18c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.IsFromAim=false&_ts=1567914660514&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246aa28c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
94 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?User.NpiNumber=1518074491&_ts=1567914660514&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246aa38c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
default
c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://c.lytics.io/c/43bffbce6f25564c8e2145a11836ff9f/default?gtm.start=1567914659790&event=gtm.js&gtm.uniqueEventId=3&_ts=1567914660514&_nmob=t&_device=desktop&url=www.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&_uid=1b8b3958c6e84842b6c08f6862b387a5&_getid=t&_v=2.0.0&_ca=jstag1
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
status
200
access-control-allow-methods
GET, POST
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
cf-ray
512df6246aa48c8c-VIE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Cookie, *
content-length
35
expires
0
1b8b3958c6e84842b6c08f6862b387a5
api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/ 		178 KB
27 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://api.lytics.io/api/content/recommend/43bffbce6f25564c8e2145a11836ff9f/user/_uid/1b8b3958c6e84842b6c08f6862b387a5?limit=30&contentsegment=ee9fe9a51cf2f1774e42f33abc9ca99c&shuffle=true
Requested by
Host: 1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/frontend.min.js?ver=1567085297
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.227.192.113 Mountain View, United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
113.192.227.35.bc.googleusercontent.com
Software
lytics.io 910393fbafbb08c3ef4e7267ee4b5e65ce7f6385 /
Resource Hash
06d09da7b6dc1269846bb256a13530adbc809dfd4bde87db25a291ad9fb3e29e

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
content-encoding
gzip
server
lytics.io 910393fbafbb08c3ef4e7267ee4b5e65ce7f6385
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, Authorization, Cookie, *
status
200
access-control-allow-methods
GET
content-type
application/json
access-control-allow-origin
https://www.empr.com
alt-svc
clear
via
1.1 google
pathfora.min.css
c.lytics.io/static/ 		20 KB
3 KB 		Stylesheet
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/static/pathfora.min.css
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/static/pathfora.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
58aa5964d6f5dc68b2180e943ea63b6031c0ba83e44d9815e724b10f2f615f9f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df6247aa68c8c-VIE
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
cf-cache-status
HIT
last-modified
Wed, 03 Jul 2019 23:03:58 GMT
server
cloudflare
age
5961
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css; charset=utf-8
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sun, 08 Sep 2019 05:51:00 GMT
config.js
c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/ 		70 KB
8 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://c.lytics.io/api/program/campaign/config/43bffbce6f25564c8e2145a11836ff9f/config.js
Requested by
Host: c.lytics.io
URL: https://c.lytics.io/api/tag/43bffbce6f25564c8e2145a11836ff9f/lio.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::6819:5365 , United States, ASN13335 (CLOUDFLARENET - Cloudflare, Inc., US),
Reverse DNS
Software
cloudflare /
Resource Hash
01d85dfaea9df031f91e2d2c8d9cdf18a2c59a086a273766f138077e1e67962f

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

cf-ray
512df6247aa78c8c-VIE
date
Sun, 08 Sep 2019 03:51:00 GMT
via
1.1 google
cf-cache-status
HIT
server
cloudflare
age
5576
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript
status
200
cache-control
public, max-age=7200
content-encoding
br
expires
Sun, 08 Sep 2019 05:51:00 GMT
registration-profession
subapi.haymarketmedia.com/ 		589 B
876 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://subapi.haymarketmedia.com/registration-profession?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
808e5dda9ebf9cae0ae42a7f53c8c335e6f2951724c8a58c15658d0fdd49b61f

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-powered-by
Express
etag
W/"24d-pNT5lZLPsLHhX4AYX72K6qXLTk4"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
589
registration-specialty
subapi.haymarketmedia.com/ 		2 KB
2 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://subapi.haymarketmedia.com/registration-specialty?countryCode=US
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-reg-js/develop/production/hmi-registration-ui.vendor.js?ver=0.1.1
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.172.78.117 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-35-172-78-117.compute-1.amazonaws.com
Software
/ Express
Resource Hash
2ccc2d6a6ce64b8e30228624183547c2456f8d9597ca456d147f47e95f4fe443

Request headers

Accept
application/json, text/plain, */*
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
x-powered-by
Express
etag
W/"686-ZUbw46JA9hG3Fv9uXg61Vkj0+q0"
status
200
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/json; charset=utf-8
access-control-allow-origin
*
access-control-allow-credentials
true
access-control-allow-headers
Content-Type, Connection, Keep-Alive, Content-Length
content-length
1670
truncated
/ 		88 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
65af014c9562d3ef38dbb4638bef464aa19d2c5899e1872b6ec96da9046168e5

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/svg+xml;charset=utf-8
type_1_diabetes_G_10559759981.jpg
www.empr.com/wp-content/uploads/sites/7/2019/06/ 		178 KB
179 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/06/type_1_diabetes_G_10559759981.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a9cdd47c48be5dee54d9e120e0455b78ce1235cfa4436c014664b36a1fb85825
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Sun, 23 Jun 2019 07:12:19 GMT
server
nginx
etag
"392e34736cb2c18080f336e02adfeffe"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
182698
expires
Tue, 08 Oct 2019 03:51:00 GMT
helicobacterpylori_994535.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		71 KB
71 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/helicobacterpylori_994535.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
eb00a1d6c88e2ded946653fdc6acbd90ffd006038de826afa1f0c18ce00383fb
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 03:48:14 GMT
server
nginx
etag
"55526f0cb2ce17919ed2f0e67b283ed9"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
72839
expires
Tue, 08 Oct 2019 03:51:00 GMT
fasttrack_1056808.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		124 KB
125 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/fasttrack_1056808.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3953890072d74373879c64d9a9846f382fe6239fff59aadf94d0152f55018ddf
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 19:56:50 GMT
server
nginx
etag
"ba3b34450aa280434b1e84e7d0a25cff"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
127121
expires
Tue, 08 Oct 2019 03:51:00 GMT
nuzyraparatek_1491258.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		15 KB
15 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/nuzyraparatek_1491258.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
25aefb7f45686d9ce0448020ae1e05ebe7ac79bd7648b1bd19d4121cdc32b478
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 00:10:56 GMT
server
nginx
etag
"a459a3c0c0d1c1b190b2db9fe193debe"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
14962
expires
Tue, 08 Oct 2019 03:51:00 GMT
lungsns_966672.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		165 KB
165 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/lungsns_966672.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c1cd0f47be532dfbdca3d65a09e8bc66347ae8180205e5ee663e2917a7717031
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 21:56:27 GMT
server
nginx
etag
"ac67eb52abe8ba789547cac50305c2b2"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
168954
expires
Tue, 08 Oct 2019 03:51:00 GMT
priorityreviewro_971534.png
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		226 KB
226 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/priorityreviewro_971534.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
f0cdf99c519889e0c4c1090e4315edeead37cc2b838d4d2d175816a1fe9e5646
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 23:50:08 GMT
server
nginx
etag
"49ccefdbb3a0563f61f1d40a71723ebe"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
231064
expires
Tue, 08 Oct 2019 03:51:00 GMT
tuberculosisfinger_1486773.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		10 KB
10 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/tuberculosisfinger_1486773.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
451a4dbdce56f4af3242ac9186499b2b18c9dc10fc014e7a8f8b2b4b0fb1317f
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 23:42:47 GMT
server
nginx
etag
"664994985d338fd4f86eae07eaef2dda"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
10266
expires
Tue, 08 Oct 2019 03:51:00 GMT
pregnantwomannl_295438.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		25 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/pregnantwomannl_295438.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c28c0ab203200c698139f50a8fd95a68a0d08969336442bd297229b9cf86f11e
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 19:56:33 GMT
server
nginx
etag
"c6024c2b663e2a839f01bc349dacb35e"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
25299
expires
Tue, 08 Oct 2019 03:51:00 GMT
arthritickneeg103772362_1526230.jpg
www.empr.com/wp-content/uploads/sites/7/2019/02/ 		12 KB
12 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/arthritickneeg103772362_1526230.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6d3e492436622e6a352603b7d0a2d686b23474ba251edbb178c97682b3b42417
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 09:13:32 GMT
server
nginx
etag
"ff144437a2163c0188f0f7e824e0abf3"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
11920
expires
Tue, 08 Oct 2019 03:51:00 GMT
sandozlogo_1489521.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		17 KB
18 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/sandozlogo_1489521.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
5b15286cb35c1034d73f02ff209d3d13719991c41748ccf58f16e89cb7443031
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 23:52:20 GMT
server
nginx
etag
"fbd4021e7a62a801098b782755fd38c4"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
17743
expires
Tue, 08 Oct 2019 03:51:00 GMT
Wakix-bottles.jpg
www.empr.com/wp-content/uploads/sites/7/2019/08/ 		40 KB
40 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/08/Wakix-bottles.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
410c36c939a8ed50176fc7471d0da5b3a5b5b6905c35680554bb36ea03f20664
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 28 Aug 2019 07:11:35 GMT
server
nginx
etag
"5e8c74df2dce0e9358f70e7644af667c"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
40535
expires
Tue, 08 Oct 2019 03:51:00 GMT
hedgehogg941863626_1526057.jpg
www.empr.com/wp-content/uploads/sites/7/2019/02/ 		31 KB
31 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/02/hedgehogg941863626_1526057.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
0fd9aa690754c17c3ca65594f8a39b39094e071a825d5bcd2852bb09ff883d6a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 09:12:51 GMT
server
nginx
etag
"0de3a1f593d389aa675aed55ba1820a4"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
31930
expires
Tue, 08 Oct 2019 03:51:00 GMT
FDA-HQ-1.jpg
www.empr.com/wp-content/uploads/sites/7/2019/04/ 		44 KB
44 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2019/04/FDA-HQ-1.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
3622b951ea76b210435cfe0389822bfbeb3c690133e6c6fd4724c335b594420a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Sun, 28 Apr 2019 07:11:12 GMT
server
nginx
etag
"281477ab9f7eb60e6b7d1f61e45fe582"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
45105
expires
Tue, 08 Oct 2019 03:51:00 GMT
480958bacteriasuperbugmrsans_961306.png
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		215 KB
215 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/480958bacteriasuperbugmrsans_961306.png
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c815514d1af0f8fd1c1e7ae5f655a694ea0174d35c1db3cec455131491e5fd4d
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 19:49:51 GMT
server
nginx
etag
"bf30eea62284f7d4eb906678440b461e"
x-frame-options
SAMEORIGIN
content-type
image/png
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
219934
expires
Tue, 08 Oct 2019 03:51:00 GMT
heartanatomyss619251317_1337421.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		25 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/heartanatomyss619251317_1337421.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8ebcc6e255a652ad4b3704586253945abee4a7837937d58e7a6f050748ce73b0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 00:12:16 GMT
server
nginx
etag
"29aaa59cecadb8dd11c2bd199f12456d"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
25233
expires
Tue, 08 Oct 2019 03:51:00 GMT
womanpainfibromyalgiass714_1319493.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		17 KB
17 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/womanpainfibromyalgiass714_1319493.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
12494375d96c61ac2a08678337880f155723ef5bff70ec710457d54277ce7ae1
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 01:43:26 GMT
server
nginx
etag
"0113c774ef8614e0ee5a98986e99449c"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
17607
expires
Tue, 08 Oct 2019 03:51:00 GMT
orphandrugns_1001134.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		99 KB
99 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/orphandrugns_1001134.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
98a61fed7de6a5c75832311d91304c00452e1d6cd6f7a52c6caf2fe0ae5e6ae3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 01:48:21 GMT
server
nginx
etag
"2a5dcea17f36dac1ec0834d867995982"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
100894
expires
Tue, 08 Oct 2019 03:51:00 GMT
dsuviaapplicator_1495784.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		12 KB
12 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/dsuviaapplicator_1495784.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
da7767cff027df59981c24026ba0a5e75adfa7af9f6194e2a407b410f61c74a2
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 01:41:53 GMT
server
nginx
etag
"8d2c05210fdd2405b7c4e1d078eb0601"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
12020
expires
Tue, 08 Oct 2019 03:51:00 GMT
marijuanag962954284_1508308.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		197 KB
197 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/marijuanag962954284_1508308.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
c3718e6f54bf83a26bbf4ac937b669bef242d2a60c74512aa5d96551fcec56b3
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 22:00:02 GMT
server
nginx
etag
"9c12a76bcea9cfbb8b50e035de916a9b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
201539
expires
Tue, 08 Oct 2019 03:51:00 GMT
hospitalroomg536907565_1490839.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		29 KB
29 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/hospitalroomg536907565_1490839.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a8a0e6b52ee335dc5282680c7a4d6aae56351925539dae786f4b8d32cdabe451
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 03:46:37 GMT
server
nginx
etag
"ea42ecdc157f48c83d75569d2c4dc77c"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
29654
expires
Tue, 08 Oct 2019 03:51:00 GMT
diabeteswordstethoscopess4_1161209.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		198 KB
198 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/diabeteswordstethoscopess4_1161209.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
2a3c8fc442100be71fa62aecfe6c6db82d0074d9b5b982940fb96dc402afb703
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 02:16:44 GMT
server
nginx
etag
"5f22abd2a5ef67a3b2900b245acc55bf"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
202699
expires
Tue, 08 Oct 2019 03:51:00 GMT
angioedemalipss394597276_1170558.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		129 KB
129 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/angioedemalipss394597276_1170558.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
d0ba350f51daaad5b6aba1fe254ff69e7fb5a1093df1181351b5f177e3a1f6c8
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 23:52:55 GMT
server
nginx
etag
"2b04f0fb16421861d24d79460712afce"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
131966
expires
Tue, 08 Oct 2019 03:51:00 GMT
girlpatientg508857401_1498856.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		20 KB
21 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/girlpatientg508857401_1498856.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
6655dda7443b326bf955416e3c2c9ffb1cd0fd618a057129037b67a2a3cb0890
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 02:10:46 GMT
server
nginx
etag
"fcdc2eb2a60cf6d5661049c96148f030"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
20724
expires
Tue, 08 Oct 2019 03:51:00 GMT
blurredpostophospitalroom_1200787.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		129 KB
129 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/blurredpostophospitalroom_1200787.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
045f6ff8e99f41737a9712df79cc2d473194287623981689a1efe9384afd4a00
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Thu, 21 Mar 2019 02:11:29 GMT
server
nginx
etag
"decb997aad20cdb04ec26bd763061c1b"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
131962
expires
Tue, 08 Oct 2019 03:51:00 GMT
type_1_diabetes_G_10559759981.jpg
www.medicalbag.com/wp-content/uploads/sites/19/2019/07/ 		178 KB
179 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.medicalbag.com/wp-content/uploads/sites/19/2019/07/type_1_diabetes_G_10559759981.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
52.4.150.177 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-52-4-150-177.compute-1.amazonaws.com
Software
nginx /
Resource Hash
a9cdd47c48be5dee54d9e120e0455b78ce1235cfa4436c014664b36a1fb85825
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:01 GMT
last-modified
Sun, 28 Jul 2019 07:12:20 GMT
server
nginx
etag
"392e34736cb2c18080f336e02adfeffe"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
182698
expires
Tue, 08 Oct 2019 03:51:01 GMT
robaxinrecalllabelcoverimg_1489569.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		29 KB
29 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/robaxinrecalllabelcoverimg_1489569.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
ff94a9877970d64c24c296c985fdc91b8cb3f45e0043ac7d1776c9371b6c9924
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 19:25:09 GMT
server
nginx
etag
"25c1cdfbf45ef0e783c42842a5151cfc"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
29341
expires
Tue, 08 Oct 2019 03:51:00 GMT
lupinlogons_950795.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		67 KB
67 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/lupinlogons_950795.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
63df35f91cbcdaeaebd41e3612c181201e3b9a219c0cfb4e03390aa41aa3dbc0
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 23:41:12 GMT
server
nginx
etag
"408b27cf5a87831592c552b52e593a85"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
68374
expires
Tue, 08 Oct 2019 03:51:00 GMT
pancreasss621789077_1372604.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		24 KB
24 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/pancreasss621789077_1372604.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
7b4b8578e192616daee058eeae034ec0b9e70a476733957e1c9ba984ec259a43
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 21:50:57 GMT
server
nginx
etag
"5502b79070db99e8f54365ddd8148f2e"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
24738
expires
Tue, 08 Oct 2019 03:51:00 GMT
autismspectrumg478570600_1404783.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		30 KB
30 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/autismspectrumg478570600_1404783.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
916440c0da7c4574d8730c8440a886e3b2ecc69e9f9a04029db859c9c2e72b47
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 09:14:24 GMT
server
nginx
etag
"6306c081655e8ce2714c1322ce274645"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
30289
expires
Tue, 08 Oct 2019 03:51:00 GMT
psilocybecubensisg868014788_1488553.jpg
www.empr.com/wp-content/uploads/sites/7/2018/12/ 		25 KB
25 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.empr.com/wp-content/uploads/sites/7/2018/12/psilocybecubensisg868014788_1488553.jpg
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
3.226.58.85 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-3-226-58-85.compute-1.amazonaws.com
Software
nginx /
Resource Hash
8744ced6470d0961297be478b4f7e25cbb8a1638af4724a7b288ed9e9d79281a
Security Headers
Name Value
X-Frame-Options SAMEORIGIN

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

x-amz-server-side-encryption
AES256
date
Sun, 08 Sep 2019 03:51:00 GMT
last-modified
Wed, 20 Mar 2019 21:35:10 GMT
server
nginx
etag
"d27793312d362e7c469a592603df6968"
x-frame-options
SAMEORIGIN
content-type
image/jpeg
status
200
cache-control
max-age=2592000
accept-ranges
bytes
content-length
25366
expires
Tue, 08 Oct 2019 03:51:00 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		4 KB
3 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3178473238769295&correlator=2320599764082143&output=ldjh&callback=googletag.impl.pubads.callbackProxy1&impl=fif&adsid=NT&vrg=2019082901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190908&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2FOOP_prestitial&sz=1x1&ists=1&scp=pos%3DOOP_prestitial&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123438%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCardiovascular_Disease%252CHyperlipoproteinemias%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLMNL_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie_enabled=1&bc=31&abxe=1&lmt=1567914660&dt=1567914660859&dlt=1567914659224&idt=602&frm=20&biw=1585&bih=1200&oid=3&adx=0&ady=4006&adk=2574155320&uci=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&dssz=78&icsg=38070590111748&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1585x4007&msz=1585x1&blev=1&bisch=1&ga_vid=1173771773.1567914660&ga_sid=1567914661&ga_hid=1377465944&fws=4&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
05b1ea08f117ec4896f1bf40d82b2ced2d099c7db851865e83cdd407aa0e78bd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
2067
x-xss-protection
0
google-lineitem-id
132788185
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138274708445
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
pubads_impl_rendering_2019082901.js
securepubads.g.doubleclick.net/gpt/ 		66 KB
25 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
sffe /
Resource Hash
05e529a757d25aa9d160d28e57c20041eee3f973870c0f0ad4ac7c21937254b1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Thu, 29 Aug 2019 13:06:32 GMT
server
sffe
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
25315
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:00 GMT
container.html
tpc.googlesyndication.com/safeframe/1-0-35/html/ 		0
0
universal-tag.js
ads.spotible.com/tag/ Frame 3866 		4 KB
2 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.spotible.com/tag/universal-tag.js
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
8a846df9c01f4d8d8b6e82c6e505069104280430b3b05d94a13a5b99d7c854aa

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Content-Encoding
gzip
ETag
"5c736e518f66ceaaee6badc00016e1a5"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=3600
Connection
keep-alive
Content-Length
1767
truncated
/ Frame 3866 		217 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
c821c10828dbb5b9d7122cdd6e294ee6e2501d88891b30a4d8edc0bec761737f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/ 		76 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
7b50f00b4ec8c413fdfcf5ccb596f9ae3f47f776ae7fd913eab6cdda0e1543e9
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:00 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1567595695661868"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28441
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:00 GMT
/
adtrackapi.haymarketmedia.com/adverttracking/ 		2 B
365 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:5e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sun, 08 Sep 2019 03:51:01 GMT
via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
4df0c629-8c5b-4f0e-816a-9e29f3357850
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d747aa5-28826734ab8b978cf26ed740;Sampled=0
x-amz-apigw-id
frgZ3GLCoAMF82A=
content-length
2
x-amz-cf-id
r8uAWa0HvBlErKV9bSPs0L6k8BGRfyO_HlPJ4P8533Le8jOpqzghqw==
creative-delivery.js
ads.spotible.com/creative/bmMb/ 		58 KB
20 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://ads.spotible.com/creative/bmMb/creative-delivery.js
Requested by
Host: ads.spotible.com
URL: https://ads.spotible.com/tag/universal-tag.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
2df541ba2dac12759f5cc36999736a318e366452d683593b713ca1a53d1e27e5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:00 GMT
Content-Encoding
gzip
ETag
"c1d949de721a6052e9634dc663595413"
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
no-cache
Connection
keep-alive
Content-Length
19905
MPR-lightbox_640x480-july19_Q.gif
cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/ 		685 KB
686 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://cdn1.spotible.com/hashed/a0bb68f349c5a16009bb7cf6d5bab3bb/MPR-lightbox_640x480-july19_Q.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.77 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-77.fra53.r.cloudfront.net
Software
/
Resource Hash
ad15e0951b55982ad0447c99a54cc497669f65c84ac6b12616891fec5f51223c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 02 Jul 2019 21:06:07 GMT
via
1.1 cc77875ec7dfc885cffaa2ec6fa578f6.cloudfront.net (CloudFront)
age
334212
etag
"a0bb68f349c5a16009bb7cf6d5bab3bb"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
701058
x-amz-cf-id
ShW61pAco73jLwKyBIY-q5F00lpPUFao_FosNXOU2JnRCyrYe8SiLw==
ads
securepubads.g.doubleclick.net/gampad/ 		19 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3178473238769295&correlator=2320599764082143&output=ldjh&callback=googletag.impl.pubads.callbackProxy2&impl=fif&adsid=NT&vrg=2019082901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190908&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fleaderboard_top&sz=728x90&scp=pos%3Dleaderboard_top&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123438%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCardiovascular_Disease%252CHyperlipoproteinemias%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLMNL_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D5feed609881dd5e5%3AT%3D1567914660%3AS%3DALNI_MZZ1jje7zxoPM3WFeDBk7Iay47qbQ&cookie_enabled=1&bc=31&abxe=1&lmt=1567914661&dt=1567914661563&dlt=1567914659224&idt=602&frm=20&biw=1585&bih=1200&oid=3&adx=193&ady=140&adk=3073216299&uci=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&dssz=80&icsg=152282360446980&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x-1&msz=1200x-1&blev=1&bisch=1&psts=CjQI2d-oP-gB3bfCjoMEggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR_cX9mlHRApPZehQrkKVj&ga_vid=1173771773.1567914660&ga_sid=1567914661&ga_hid=1377465944&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
9fa2640b8005be92ff9665d4edb4c796598d65b306ee9459b4fb1338ab2aea83
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:01 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5802
x-xss-protection
0
google-lineitem-id
5144421111
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138278274851
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
Cookie set rt=ifr
bcp.crwdcntrl.net/5/c=14413/rand=618027801/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%2... Frame A384 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://bcp.crwdcntrl.net/5/c=14413/rand=618027801/pv=y/ver=1.4/int=%23OpR%2396858%23Total%20Site%20Traffic%20%3A%20www.empr.com/int=%23OpR%2396859%23www.empr.com%20%3A%20Site%20Section%20%3A%20home/int=%23OpR%2396860%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%20%3A%20news/int=%23OpR%2397492%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20drugs-in-the-pipeline/int=%23OpR%2397493%23www.empr.com%20%3A%20Site%20Section%20%3A%20home%20%3A%20news%20%3A%20drugs-in-the-pipeline%20%3A%20twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/med=%23OpR%2397539%23Article%20Tags%20%3A%20Cardiovascular%20Disease%2CHyperlipoproteinemias/rb=%7B%22url%22%3A%22https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933%22%7D/rt=ifr
Requested by
Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/14413/cc.js?ver=1.4&ns=_cc14413
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.248.146.79 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-3-248-146-79.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Host
bcp.crwdcntrl.net
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
Sec-Fetch-Site
cross-site
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Accept-Encoding
gzip, deflate, br
Cookie
_cc_dc=1; _cc_id=b77d9ea389e1e4a3e981fa427341876f; _cc_cc="ACZ4nGNQSDI3T7FMTTS2sEw1TDVJNE61tDBMSzQxMjc2MbQwN0tjAILYkqolDAgAAFnpCrg%3D"; _cc_aud="ABR4nGNgYGCILalawgAHABfQAfA%3D"
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

Access-Control-Allow-Origin
*
Cache-Control
no-cache
Content-Encoding
gzip
Content-Type
text/html;charset=UTF-8
Date
Sun, 08 Sep 2019 03:51:01 GMT
Expires
0
P3P
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
Pragma
no-cache
Set-Cookie
_cc_id=b77d9ea389e1e4a3e981fa427341876f;Path=/;Domain=crwdcntrl.net;Expires=Thu, 04-Jun-2020 03:06:00 GMT;SameSite=None _cc_cc="ACZ4nGNQSDI3T7FMTTS2sEw1TDVJNE61tDBMSzQxMjc2MbQwN0tjAILYkqql%2F4GAnwEGeM%2F3n1BkPFvA8J%2BRkeH6zBY4u3c6gt2wuAvOPjUZIT79hDqM%2BWBqDyOM%2FfGzJYx5%2BfkdWRj78OI5LDD2BST2pVOP2GDs%2FcuPwtUDANBRRzY%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Thu, 04-Jun-2020 03:06:00 GMT;Max-Age=23328000;SameSite=None _cc_aud="ABR4nGNgYGCILalaygADTAwcV2pBDI7bh4AkAEpdBPE%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Thu, 04-Jun-2020 03:06:00 GMT;Max-Age=23328000;SameSite=None
Vary
Accept-Encoding
X-Server
10.45.2.104
Content-Length
693
Connection
keep-alive
cs.js
sb.scorecardresearch.com/c2/21948019/ 		0
400 B 		Script
General
Check archive.org
Download Go to
Full URL
https://sb.scorecardresearch.com/c2/21948019/cs.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-5XFK9V6
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
104.111.214.103 , Netherlands, ASN16625 (AKAMAI-AS - Akamai Technologies, Inc., US),
Reverse DNS
a104-111-214-103.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:01 GMT
Content-Encoding
gzip
Last-Modified
Fri, 08 Apr 2011 23:11:26 GMT
ETag
"d41d8cd98f00b204e9800998ecf8427e:1349196464"
Vary
Accept-Encoding
Content-Type
application/x-javascript
Cache-Control
private, no-transform, max-age=259200
Connection
keep-alive
Content-Length
20
Expires
Wed, 11 Sep 2019 03:51:01 GMT
init-121b5si20pnxjymcwdz.js
api.b2c.com/api/ 		12 KB
5 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://api.b2c.com/api/init-121b5si20pnxjymcwdz.js?isNHT=false
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
c8dddbd62da7c02f256caa9a3518d3db27b07f54721ff4c917a24d90407279a5

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
collect
www.google-analytics.com/ 		35 B
133 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1377465944&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&ul=en-us&de=UTF-8&dt=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=lytics_refresh&ea=undefined&_u=aGDAAAAjQ~&jid=&gjid=&cid=1173771773.1567914660&tid=UA-1290429-2&_gid=1002369859.1567914660&gtm=2wg8l25XFK9V6&cd20=ga_med_nomycme%2Cga_med_nht_false%2Call%2Cga_med_unknown&cd21=&cd22=&cd23=&cd24=&cd25=&cd26=&cd27=&cd28=&cd29=&cd30=Normal%20(67%20segments%20found)&z=1334674220
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 03 Sep 2019 23:49:17 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
360104
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
up
insight.adsrvr.org/track/ Frame FF81 		0
0 		Document
General
Check archive.org
Download Go to
Full URL
https://insight.adsrvr.org/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&upid=7fhq4wn&upv=1.1.0
Requested by
Host: js.adsrvr.org
URL: https://js.adsrvr.org/up_loader.1.1.0.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.51.120.75 Dublin, Ireland, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-51-120-75.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

:method
GET
:authority
insight.adsrvr.org
:scheme
https
:path
/track/up?adv=wxli9bh&ref=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&upid=7fhq4wn&upv=1.1.0
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
sec-fetch-mode
nested-navigate
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3
sec-fetch-site
cross-site
referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Sec-Fetch-Mode
nested-navigate
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933

Response headers

status
200
date
Sun, 08 Sep 2019 03:51:01 GMT
content-type
text/html
cache-control
private,no-cache, must-revalidate
pragma
no-cache
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
collect
www.google-analytics.com/ 		35 B
93 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google-analytics.com/collect?v=1&_v=j79&a=1377465944&t=event&ni=1&_s=1&dl=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&ul=en-us&de=UTF-8&dt=Twice-Yearly%20Cholesterol-Lowering%20Therapy%20Effective%20in%20Phase%203%20Trial%20-%20MPR&sd=24-bit&sr=1600x1200&vp=1585x1200&je=0&ec=Scroll%20Depth&ea=%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F&el=25%25&ev=25&_u=aGDAAAAjQ~&jid=&gjid=&cid=1173771773.1567914660&tid=UA-1290429-2&_gid=1002369859.1567914660&gtm=2wg8l25XFK9V6&z=600884851
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
8337212354871836e6763a41e615916c89bac5b3f1f0adf60ba43c7c806e1015
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 03 Sep 2019 23:49:17 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
age
360104
status
200
content-type
image/gif
access-control-allow-origin
*
cache-control
no-cache, no-store, must-revalidate
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
35
expires
Mon, 01 Jan 1990 00:00:00 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame B0D5 		0
75 B 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsvs--QFHpsbrLinbuDMhwp_W6aOka84y93wfJEuz1R21gFQO1gz449rxP7IGO9Yg1o1kqzlYbBXYWRUIfyuRJTHqeo3rVPo97LW_yF8N5Nn6w52nTj5ghPSqrNpnh9Gq3urdAt2MuvNjiPHXYWpdEbueKcbQoitXidFuJoiZ1K6Rfdca7euvD8_rcP0D2lwOMpgpbAK3FCiu6NLczr1SQ5W8xS6Ql7jwOGB9f4ms4tH46d2iDYJ2vxQabUoIIySQRwG3zTIHOCmCXSAdGTMNC0Dn6sfDm6KwXO6JfihE4Vv2EES_hY2TTdX&sig=Cg0ArKJSzHPe36Ukn4TCEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:51:01 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/ Frame B0D5 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 04 Sep 2019 18:38:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
292367
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 18 Sep 2019 18:38:14 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame B0D5 		75 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fa5aad043be6924981d5d8b2041376073fa1f630c77a1b327f153e56ab91d965
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:01 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1567595695661868"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28589
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:01 GMT
l
www.google.com/ads/measurement/ Frame B0D5 		0
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaRQTGkz1rJFmj063aItTkIS-rPIDYCnfGGTKzz2Jg-pCkkKrKfImic0Q6cAAWmgna7jrcRDxQGiF6LrJn7jx20nNoCQSw
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame B0D5 		12 KB
5 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854605&AdvertiserID=27496345&OrderID=415436905&LineItemID=5144421111&CreativeID=138278274851&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&sid=Drugs_in_the_Pipeline
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
afbab7ed96175359c9222dabcbbf8236222595e93b8ae65f353dfe6cf695aa61

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
15638570741095414737
tpc.googlesyndication.com/simgad/ Frame B0D5 		30 KB
30 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/15638570741095414737
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
892ff0b3166742d839aeb9027057d0bd3f0e9af48d70cbfa44f22952f9c1fcf0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 28 Aug 2019 04:12:41 GMT
x-content-type-options
nosniff
age
949100
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
30632
x-xss-protection
0
last-modified
Wed, 07 Aug 2019 16:56:48 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 27 Aug 2020 04:12:41 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		19 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3178473238769295&correlator=2320599764082143&output=ldjh&callback=googletag.impl.pubads.callbackProxy3&impl=fif&adsid=NT&vrg=2019082901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190908&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fbox_1&sz=300x250%7C300x600&scp=pos%3Dbox_1%26lid%3D5144421111&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123438%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCardiovascular_Disease%252CHyperlipoproteinemias%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLMNL_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D5feed609881dd5e5%3AT%3D1567914660%3AS%3DALNI_MZZ1jje7zxoPM3WFeDBk7Iay47qbQ&cookie_enabled=1&bc=31&abxe=1&lmt=1567914661&dt=1567914661734&dlt=1567914659224&idt=602&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=305&adk=2374356963&uci=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&dssz=82&icsg=609129441787908&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x250&msz=300x250&blev=1&bisch=1&psts=CjQI2d-oP-gB3bfCjoMEggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR_cX9mlHRApPZehQrkKVj%2CCjUI98WGlRPoAaOOnJCDBIICGrG5gA_RufYhgcP2IfHtzzSKxP2aUY3E_ZpR0QLlbknPTzSVFw&ga_vid=1173771773.1567914660&ga_sid=1567914661&ga_hid=1377465944&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
4d01e91f410a379cfb91b31cab06eeef3d5217b460777eee344a0226fed5b5d3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:01 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5546
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
116494027705
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame B0D5 		216 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
e2c673ce5fb56f183f6a4492d111a684e32faf16368dc380b0ed94697dfcdd7f

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
view
securepubads.g.doubleclick.net/pcs/ Frame C8FB 		0
57 B 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssObCNQYWtPygyRfH7PBknr3dFC3NGJn-hFE3C9J5xrb7WqvIKUH3KKkzt2k2nmNIAMs8Qi5TelmYT9h1z-m6CCrDq5BHrzy6gREYfha1YJ8I03uSh3TVerVxG6njVk16TR1n1Lo86mzKvU6R2cdxwN79Qa4lTvbA0iNfFfJKqmiKqUTPXHTArQYmv-o7mh4j5hN05zJSORQZGjKsRYwx4q7dGGPRrIvNNySyvc2hjaZDPRcznV3Q6iGo0Jl1gmBovXrxT21Yku5jvjz3MHpFUAlOch-WwkQsceqcwEXQ&sig=Cg0ArKJSzOg_r9DclypLEAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:51:01 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/ Frame C8FB 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 04 Sep 2019 18:38:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
292367
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 18 Sep 2019 18:38:14 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame C8FB 		75 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fa5aad043be6924981d5d8b2041376073fa1f630c77a1b327f153e56ab91d965
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:01 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1567595695661868"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28589
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:01 GMT
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame C8FB 		12 KB
5 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854830&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=116494027705&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&sid=Drugs_in_the_Pipeline
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
9723c318049b2ba7162206a545e0a8372865d42dcfc9a200492ca4e98fad0331

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
8299312168136675521
tpc.googlesyndication.com/simgad/ Frame C8FB 		90 KB
90 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/8299312168136675521
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
e98ee80eff9057ec97269e5a00f640221bbdb5cbfbeebc82e09034cd36c32fb0
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Tue, 03 Sep 2019 23:35:10 GMT
x-content-type-options
nosniff
age
360951
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
92358
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:20:51 GMT
server
sffe
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Wed, 02 Sep 2020 23:35:10 GMT
ads
securepubads.g.doubleclick.net/gampad/ 		20 KB
6 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3178473238769295&correlator=2320599764082143&output=ldjh&callback=googletag.impl.pubads.callbackProxy4&impl=fif&adsid=NT&vrg=2019082901&guci=1.2.0.0.2.2.0.0&plat=1%3A32776%2C2%3A16809992%2C8%3A134250504&sc=1&sfv=1-0-35&ecs=20190908&iu=%2F5745%2Fmpr_us%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Fbox_2&sz=300x250&scp=pos%3Dbox_2%26lid%3D5144421111%2C132783265&eri=1&cust_params=pagetype%3Dpost%26sponsor%3D%26comp%3D%26author%3DDiana%2520Ernst%252C%2520RPh%26postID%3D123438%26env%3Dlive%26sid%3DDrugs_in_the_Pipeline%26styleid%3D%26cat%3DCardiovascular_Disease%252CHyperlipoproteinemias%26atype%3DMPR_Drug_News%26block%3Dmpr_basaglar042616%26isnht%3Dfalse%26browser%3DChrome%252074%26amid%3D%26spr%3D%26ssp%3D%26cpn%3Dim_all%252Cpcp_all%252CPVC2019127035%252Cpcp_md%252CEmaglityMMJuly30DMD%252CEmaglityLMNL_Aug28DH%26LyticsSegments%3Dga_med_nomycme%252Cga_med_nht_false%252Cmycme_rheum_survey_audience%252C3_day_visitors_neuro_ca_empr%252Cblackfriday_notunknown%252Cactivity_5126_audience%252Cmycme_endofyearsale_noanonymous_nosdc%252Caudience_for_mlk_sale%252Cnot_unknown_5770%252Cmycme_activity_5762%252Cddw_opened_to_all%252Call%252Csmt_new%252Cly_reporting_from_email%252Cly_reporting_has_visited_web%252Cly_reporting_multi_session_visitor%252Cly_reporting_last_visit_within_day%252Cly_reporting_last_visit_within_week%252Cly_reporting_last_visit_within_month%252Cly_reporting_last_visit_within_3_months%252Cly_unknown_email%252Cly_repeat_visitor%252Cly_international_visitor%252Cly_uses_desktop%252Cly_from_email%252Call_time_visitors%252Cmycme_allergy_all_except_4797_completes%252Cmycme_hiv_all_except_4670_completes%252Cmycme_internal_med_all_except_4670_completes%252Cmycme_allergy_all_except_4744_completes%252Cmycme_psychiatry_all_except_4812_completes%252Cmycme_cardiology_all_except_cardiology_pas%252Cmycme_dermatology_all_except_4831_completes%252Cmycme_pediatrics_all_except_4354_completes%252Cmycme_acc_next_activity_promo_no_4523%252Cmycme_acc_next_activity_promo_no_4524%252Cmycme_acc_next_activity_promo_no_4525%252Cmycme_acc_next_activity_promo_no_4526%252Cmycme_acc_next_activity_promo_no_4593%252Cmycme_acc_next_activity_promo_no_4595%252Cmycme_acc_next_activity_promo_no_4710%252Cmycme_acc_next_activity_promo_no_4804%252Cmycme_acc_next_activity_promo_no_4834%252Cmycme_acc_next_activity_promo_no_4800%252Cmycme_acc_next_activity_promo_no_4792%252Cmycme_acc_next_activity_promo_no_4511%252Cmycme_acc_next_activity_promo_no_4529%252Cmycme_acc_next_activity_promo_no_4558%252Cmycme_acc_next_activity_promo_no_4634%252Cmycme_impact_next_activity_promo_no_4740%252Cmycme_impact_next_activity_promo_no_4757%252Cmycme_impact_next_activity_promo_no_4842%252Cmycme_impact_next_activity_promo_no_4816%252Cmycme_impact_next_activity_promo_no_4897%252Cmycme_impact_next_activity_promo_no_4727%252Cmycme_impact_next_activity_promo_no_4755%252Cmycme_impact_next_activity_promo_no_4791%252Cmycme_impact_next_activity_promo_no_47911%252Cmycme_impact_next_activity_promo_no_4826%252Cmycme_impact_next_activity_promo_no_4815%252Cce_excluding_mpr_print_subscribers%252Cce_excluding_ca_print_subscribers%252Cga_med_unknown%252Cmycme_homepage_ibs_town_wall_%252Cmycme_ddw_nash%252Cmycme_activity_5841_2%252Cmycme_pediatrics_activity_5591&cookie=ID%3D5feed609881dd5e5%3AT%3D1567914660%3AS%3DALNI_MZZ1jje7zxoPM3WFeDBk7Iay47qbQ&cookie_enabled=1&bc=31&abxe=1&lmt=1567914661&dt=1567914661923&dlt=1567914659224&idt=602&frm=20&biw=1585&bih=1200&oid=3&adx=1053&ady=1176&adk=2198966543&uci=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.empr.com%2Fhome%2Fnews%2Fdrugs-in-the-pipeline%2Ftwice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial%2F%3Futm_source%3Dnewsletter%26utm_medium%3Demail%26utm_campaign%3Dmpr-dailydose-dmd-20190908%26cpn%3Dim_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH%26hmSubId%3D%26hmEmail%3DHU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0%26NID%3D1518074491%26c_id%3D%26email_hash%3D44dea3cd4839b799f2911b5d7920d77d%26dl%3D0%26mpweb%3D1323-67302-5059933&dssz=82&icsg=609129441787908&mso=67108864&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=300x283&msz=300x250&blev=1&bisch=1&psts=CjQIobmoP-gBuZfX_LEDggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR7sX9mlHRAmXYqqwdVvZc%2CCjQI2d-oP-gB3bfCjoMEggIasbmAD9G59iGBw_Yh8e3PNIrE_ZpR_cX9mlHRApPZehQrkKVj%2CCjUI98WGlRPoAaOOnJCDBIICGrG5gA_RufYhgcP2IfHtzzSKxP2aUY3E_ZpR0QLlbknPTzSVFw&ga_vid=1173771773.1567914660&ga_sid=1567914661&ga_hid=1377465944&fws=516&ohw=1585
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
facd852bdf30245933371cf30b257a7cbfb29226529c5d706fa67b13efaa45cf
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
5707
x-xss-protection
0
google-lineitem-id
132783265
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138231809754
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.empr.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
truncated
/ Frame C8FB 		206 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
4293dfcd7f7017f89bdc1fedc7805a570788528d7f85f34ea77f881119eba953

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/ 		2 B
366 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:5e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sun, 08 Sep 2019 03:51:02 GMT
via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
246ffa1b-3be6-4523-a73f-075bb8fc1edd
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d747aa6-33912684772bf1f4b086fd48;Sampled=0
x-amz-apigw-id
frgaAESdoAMF--Q=
content-length
2
x-amz-cf-id
pX0QSXeNOjTsilnts4SGFOlswsxXNVaH2ex4mAHQm2pVxa8rsFFKIw==
report
ads.spotible.com/creative/bmMb/ 		43 B
191 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ads.spotible.com/creative/bmMb/report?,1567914661,596001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!2,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:01 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
view
securepubads.g.doubleclick.net/pcs/ 		0
57 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsv6eEs7It-V0QQVSAhaXKPYKNYIXvHH4Vm-e2ljPKPzLksar-Lt5FnCVlh_WuC02249S4sVouF5Gi5CH16u-qItgECqmI9rN-sRRDBMwVqIcBr_R3XSP9awWUbDQjKpU6FKF36nv_1Tgvqdg-qG_S78Uit83rjmcgZ37YPxxUdiEOXsEnh9FkuCIXsrBedqgyNnjdKf04hyI3aeosHKNxJRLAbJWzConmyzcR5rvHlsTIBxPP4t5FYD8IgpqCtxI8WJbCSO42MIomD_ISY-VRMxGF15s_66REeaRa02dR52fSP-pTitXFkR7nQyWEs5t6IM3YsyxxvABjgqaO1wKXK_BYU&sai=AMfl-YQuOg_uh04mS99mZUMkcEAnIxCPwAoJq6Jz4EQMDGKHCIoAz1CdJsK-oWjX5_FKgaLw-_sawYzanlC2E4doXabR_e49RhEp0sec2Eah&sig=Cg0ArKJSzIoq5nqWNBD6EAE&urlfix=1&adurl=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:51:02 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
error_handler.js
tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/ Frame 35A2 		7 KB
3 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/error_handler.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
1b59bd0e492e82d006ecbdd2eca4c5f6a12af900e1f02edf66f05684c54882ff
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 04 Sep 2019 18:38:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
292368
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
3292
x-xss-protection
0
server
cafe
etag
7324492156235402329
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 18 Sep 2019 18:38:14 GMT
16030660017714012110
tpc.googlesyndication.com/simgad/ Frame 35A2 		48 KB
48 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://tpc.googlesyndication.com/simgad/16030660017714012110
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
4daa8b467725da84b7f12beba99f81c390ddfdffa7bda838aed65663f266941c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 04 Sep 2019 07:17:30 GMT
x-content-type-options
nosniff
age
333212
x-dns-prefetch-control
off
status
200
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
49437
x-xss-protection
0
last-modified
Thu, 02 Feb 2017 14:35:44 GMT
server
sffe
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 03 Sep 2020 07:17:30 GMT
window_focus.js
tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/ Frame 35A2 		2 KB
1 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://tpc.googlesyndication.com/pagead/js/r20190903/r20110914/client/window_focus.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:825::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
6dd7e7ea596e944778e78ccd97a2e17837ef633d69cad2108842d4ddcb958b1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Wed, 04 Sep 2019 18:38:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
292368
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status
200
content-disposition
attachment; filename="f.txt"
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
1054
x-xss-protection
0
server
cafe
etag
18205873578609640656
vary
Accept-Encoding
content-type
text/javascript; charset=UTF-8
cache-control
public, max-age=1209600
timing-allow-origin
*
expires
Wed, 18 Sep 2019 18:38:14 GMT
osd_listener.js
www.googletagservices.com/activeview/js/current/ Frame 35A2 		75 KB
28 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
sffe /
Resource Hash
fa5aad043be6924981d5d8b2041376073fa1f630c77a1b327f153e56ab91d965
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1567595695661868"
vary
Accept-Encoding
content-type
text/javascript
status
200
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
28589
x-xss-protection
0
expires
Sun, 08 Sep 2019 03:51:02 GMT
l
www.google.com/ads/measurement/ Frame 35A2 		0
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.google.com/ads/measurement/l?ebcid=ALh7CaT7qHKHKBj0ynDgOYEq3KQSYCND--cbGkJC-sLX_vnQYBUa37LfJwwmZYkoU1OCsypYNy8sMJxcSpHGaatwd9vUnWpZCQ
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81c::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers
init-132dn9au2z77uqg0m5w.js
api.b2c.com/api/ Frame 35A2 		12 KB
5 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://api.b2c.com/api/init-132dn9au2z77uqg0m5w.js?AdUnitID_TopLevel=71146705&AdUnitID=21799854854&AdvertiserID=27496345&OrderID=415436905&LineItemID=132783265&CreativeID=138231809754&CPN=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&sid=Drugs_in_the_Pipeline
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_rendering_2019082901.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:3864:1186:98a:22d7 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
f6bef77ea544bf38c01dc843fa2937eefef82c22a763a19f66adfbcfc8591b0c

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:02 GMT
content-encoding
gzip
server
openresty
content-type
text/javascript
status
200
cache-control
no-cache, no-store, must-revalidate
expires
-1
view
securepubads.g.doubleclick.net/pcs/ Frame 35A2 		0
57 B 		Fetch
General
Check archive.org
Download Go to
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuSiW3lckG_xMQ4KyTLrvC_MI4soHXwxbH6H0IT9JukKLWZNUDJWynLLFOdwylKPvEomqMZPyWQY-UlAMFPX7be-DwqD0JKZucNjTmwgGQqtK8uUj9PirDahDfqEa9oFO_pv28nkk7wCKkwXQsO5L_vk9xy2_Opnyu-Q7Y6GXtj2FCSfiDsGe3LKP7lAlRTPDQcEZMa4YZqJQyNOjV3bQntlqDh4s05e9rVOrxqCYpkh8iLtTFQyL4gVkkdtczIlsMOfAOro1Dzjx_EOEzJ1DGhsNaGMPGlQgAeldiM9Q&sig=Cg0ArKJSzOVxPpCpu2D9EAE&adurl=
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.22.98 , United States, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
fra15s18-in-f98.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

timing-allow-origin
*
date
Sun, 08 Sep 2019 03:51:02 GMT
x-content-type-options
nosniff
server
cafe
status
200
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
content-type
image/gif
alt-svc
quic=":443"; ma=2592000; v="46,43,39"
content-length
0
x-xss-protection
0
ad.gif
api-52-13-54-247.b2c.com/api/ 		43 B
233 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://api-52-13-54-247.b2c.com/api/ad.gif
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:4696:4121:90e8:18d3 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:02 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
truncated
/ Frame 35A2 		210 B
0 		Image
General
Check archive.org
Download Go to Show image
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
b64d55f0e31a1a74512763b3e84e852d2b1989d5954872e8858583acd61998b7

Request headers

User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Content-Type
image/png
/
adtrackapi.haymarketmedia.com/adverttracking/ 		2 B
366 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:5e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sun, 08 Sep 2019 03:51:02 GMT
via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
e4f66a38-0880-427f-bbb6-d2683fa8fa43
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d747aa6-c2a1498848bc29b81dd3abf0;Sampled=0
x-amz-apigw-id
frgaDGEBIAMFVbw=
content-length
2
x-amz-cf-id
wvy9dFk7_YrSJmuf9Aki1TTLPaByck_QHebZqJNNGOYLcVof9LCkbw==
ad.gif
api-54-185-17-100.b2c.com/api/ Frame C8FB 		43 B
233 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://api-54-185-17-100.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1332:efe2:4c8b:e1bc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:02 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-34-220-54-177.b2c.com/api/ Frame 35A2 		43 B
233 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://api-34-220-54-177.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:a3d2:ff9c:62:f338 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:02 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
ad.gif
api-35-164-230-125.b2c.com/api/ Frame B0D5 		43 B
233 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://api-35-164-230-125.b2c.com/api/ad.gif
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:82de:3dbd:aba5:8158 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:03 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
x
api-52-13-54-247.b2c.com/api/ 		0
382 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://api-52-13-54-247.b2c.com/api/x?WHjlZadNwGfgCYL3$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS90d2ljZS15ZWFybHktY2hvbGVzdGVyb2wtbG93ZXJpbmctdGhlcmFweS1lZmZlY3RpdmUtaW4tcGhhc2UtMy10cmlhbC8_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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:4696:4121:90e8:18d3 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:02 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
4
api-52-13-54-247.b2c.com/api/
Redirect Chain
  • https://api-52-13-54-247.b2c.com/api/x?WHjlZadNwGfgCYL3$dGltZS1kb21haW5Mb29rdXBTdGFydCQ3JDI4NCIsInRpbWUtZG9tYWluTG9va3VwRW5kJDckMjg0IiwidGltZS1jb25uZWN0U3RhcnQkNyQyODQiLCJ0aW1lLWNvbm5lY3RFbmQkNyQ0N...
  • https://api-52-13-54-247.b2c.com:444/api/4?WHjlZadNwGfgCYL3
43 B
406 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-52-13-54-247.b2c.com:444/api/4?WHjlZadNwGfgCYL3
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.13.54.247 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-52-13-54-247.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sun, 08 Sep 2019 03:51:02 GMT
Server
openresty
Location
https://api-52-13-54-247.b2c.com:444/api/4?WHjlZadNwGfgCYL3
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
/
adtrackapi.haymarketmedia.com/adverttracking/ 		2 B
365 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://adtrackapi.haymarketmedia.com/adverttracking/
Requested by
Host: s3.amazonaws.com
URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:9000:2057:5e00:16:bc48:4dc0:93a1 , United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
/
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-type
application/json

Response headers

date
Sun, 08 Sep 2019 03:51:03 GMT
via
1.1 c05282a87474a55ae2a8dd2aa77d1233.cloudfront.net (CloudFront)
x-amz-cf-pop
FRA6-C1
x-amzn-requestid
cd85b56a-aaee-4860-8b36-a590e9d5104b
status
200
x-cache
Miss from cloudfront
content-type
application/json
access-control-allow-origin
*
x-amzn-trace-id
Root=1-5d747aa6-7f6def1442baaa944d3f436a;Sampled=0
x-amz-apigw-id
frgaFEWHoAMFW2A=
content-length
2
x-amz-cf-id
U5ANt-DoHhYffQHJ29S5NIyHID7dRIIDdO__S8a81bif-nuChTbiJw==
x
api-54-185-17-100.b2c.com/api/ Frame C8FB 		0
382 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://api-54-185-17-100.b2c.com/api/x?N0OC5fhexkh01EES$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS90d2ljZS15ZWFybHktY2hvbGVzdGVyb2wtbG93ZXJpbmctdGhlcmFweS1lZmZlY3RpdmUtaW4tcGhhc2UtMy10cmlhbC8_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
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1332:efe2:4c8b:e1bc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
4
api-54-185-17-100.b2c.com/api/ Frame C8FB
Redirect Chain
  • https://api-54-185-17-100.b2c.com/api/x?N0OC5fhexkh01EES$bmF2aWdhdGlvbi1yZWRpcmVjdENvdW50JDYkMCIsIm5hdmlnYXRpb24tdHlwZSQ2JG5hdmlnYXRlIiwiZ2xvYmFscy10aW1lJDExJDAuOCIsImdsb2JhbHMkMTEkYTM3NTI1YTMiLCJk...
  • https://api-54-185-17-100.b2c.com:444/api/4?N0OC5fhexkh01EES
43 B
406 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-54-185-17-100.b2c.com:444/api/4?N0OC5fhexkh01EES
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.185.17.100 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-54-185-17-100.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Location
https://api-54-185-17-100.b2c.com:444/api/4?N0OC5fhexkh01EES
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
x
api-34-220-54-177.b2c.com/api/ Frame 35A2 		0
382 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://api-34-220-54-177.b2c.com/api/x?WWoJ47WuUZmunRpx$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS90d2ljZS15ZWFybHktY2hvbGVzdGVyb2wtbG93ZXJpbmctdGhlcmFweS1lZmZlY3RpdmUtaW4tcGhhc2UtMy10cmlhbC8_dXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW1wci1kYWlseWRvc2UtZG1kLTIwMTkwOTA4JmNwbj1pbV9hbGwscGNwX2FsbCxQVkMyMDE5MTI3MDM1LHBjcF9tZCxFbWFnbGl0eU1NSnVseTMwRE1ELEVtYWdsaXR5TE1OTF9BdWcyOERIJmhtU3ViSWQ9JmhtRW1haWw9SFU5OEMtSFV5ampJZTQ1T3BTVl8yTEh5UUstVWFHUVQwJk5JRD0xNTE4MDc0NDkxJmNfaWQ9JmVtYWlsX2hhc2g9NDRkZWEzY2Q0ODM5Yjc5OWYyOTExYjVkNzkyMGQ3N2QmZGw9MCZtcHdlYj0xMzIzLTY3MzAyLTUwNTk5MzMiLCJyZWZlcnJlciQwJCIsImFuY2VzdG9yT3JpZ2lucyQwJGh0dHBzOi8vd3d3LmVtcHIuY29tIiwidmlkZW8kMCQxNjAweDEyMDB4MjQiLCJmcmFtZSQwJDEiLCJoaWRkZW4kMCQwIiwidmlzaWJpbGl0eVN0YXRlJDAkdmlzaWJsZSIsImhhc0ZvY3VzJDAkMCIsIndpbmRvdyQwJDMwMHgyNTAiLCJpbm5lciQwJDMwMHgyNTAiLCJvdXRlciQwJDE2MDB4MTIwMCIsImxvY2FsU3RvcmFnZSQwJEVycm9yOiBUeXBlRXJyb3I6IENhbm5vdCByZWFkIHByb3BlcnR5ICdzZXRJdGVtJyBvZiBudWxsIiwic2Vzc2lvblN0b3JhZ2UkMCQxIiwiYXBwQ29kZU5hbWUkMCRNb3ppbGxhIiwiYXBwTmFtZSQwJE5ldHNjYXBlIiwiYXBwVmVyc2lvbiQwJDUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2IiwiY29va2llRW5hYmxlZCQxJHRydWUiLCJkb05vdFRyYWNrJDEkIiwiaGFyZHdhcmVDb25jdXJyZW5jeSQxJDE2IiwibGFuZ3VhZ2UkMSRlbi1VUyIsInBsYXRmb3JtJDEkTGludXggeDg2XzY0IiwicHJvZHVjdCQxJEdlY2tvIiwicHJvZHVjdFN1YiQxJDIwMDMwMTA3Iiwic2VuZEJlYWNvbiQxJDEiLCJ1c2VyQWdlbnQkMSRNb3ppbGxhLzUuMCAoTWFjaW50b3NoOyBJbnRlbCBNYWMgT1MgWCAxMF8xNF81KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvNzQuMC4zNzI5LjE2OSBTYWZhcmkvNTM3LjM2IiwidmVuZG9yJDEkR29vZ2xlIEluYy4iLCJ2ZW5kb3JTdWIkMSQiLCJmb250cmVuZGVyJDEkMSIsIndlYmdsJDIkbi9hIiwid2ViZ2wyJDIkMCIsInRpbWUkMiQxNTY3OTE0NjYyMzM2IiwidGltZXpvbmUkMiQtMTIwIiwicGx1Z2lucyQyJE5vbmUiLCJtZW0tdG90YWxKU0hlYXBTaXplJDIkMzguNzYxNTY4IiwibWVtLXVzZWRKU0hlYXBTaXplJDIkMzAuNzQ5NjcyIiwibWVtLWpzSGVhcFNpemVMaW1pdCQyJDIxOTcuODE1Mjk2IiwidGltZS1yZXNwb25zZUVuZCQyJDE
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:a3d2:ff9c:62:f338 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
4
api-34-220-54-177.b2c.com/api/ Frame 35A2
Redirect Chain
  • https://api-34-220-54-177.b2c.com/api/x?WWoJ47WuUZmunRpx$dGltZS1kb21Mb2FkaW5nJDIkMSIsInRpbWUtZG9tSW50ZXJhY3RpdmUkMiQxIiwidGltZS1kb21Db250ZW50TG9hZGVkRXZlbnRTdGFydCQyJDEiLCJ0aW1lLWRvbUNvbnRlbnRMb2Fk...
  • https://api-34-220-54-177.b2c.com:444/api/4?WWoJ47WuUZmunRpx
43 B
406 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-34-220-54-177.b2c.com:444/api/4?WWoJ47WuUZmunRpx
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.220.54.177 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-34-220-54-177.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sun, 08 Sep 2019 03:51:02 GMT
Server
openresty
Location
https://api-34-220-54-177.b2c.com:444/api/4?WWoJ47WuUZmunRpx
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
4
api-35-164-230-125.b2c.com/api/ Frame B0D5
Redirect Chain
  • https://api-35-164-230-125.b2c.com/api/x?VvXUIDQnkRauUX0a$dXJsJDAkaHR0cHM6Ly93d3cuZW1wci5jb20vaG9tZS9uZXdzL2RydWdzLWluLXRoZS1waXBlbGluZS90d2ljZS15ZWFybHktY2hvbGVzdGVyb2wtbG93ZXJpbmctdGhlcmFweS1lZmZ...
  • https://api-35-164-230-125.b2c.com:444/api/4?VvXUIDQnkRauUX0a
43 B
441 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://api-35-164-230-125.b2c.com:444/api/4?VvXUIDQnkRauUX0a
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.164.230.125 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
ec2-35-164-230-125.us-west-2.compute.amazonaws.com
Software
openresty /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:05 GMT
Last-Modified
Mon, 28 Sep 1970 06:00:00 GMT
Server
openresty
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
image/gif
Access-Control-Allow-Origin
null
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
43
Expires
-1

Redirect headers

Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Location
https://api-35-164-230-125.b2c.com:444/api/4?VvXUIDQnkRauUX0a
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/html
Access-Control-Allow-Origin
https://www.empr.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
142
x
api-35-164-230-125.b2c.com/api/ Frame B0D5 		0
382 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-35-164-230-125.b2c.com/api/x?VvXUIDQnkRauUX0a$bmF2aWdhdGlvbi10eXBlJDIkbmF2aWdhdGUiLCJnbG9iYWxzLXRpbWUkNSQwLjQyIiwiZ2xvYmFscyQ1JGEzNzUyNWEzIiwiZG9jdW1lbnQtdGltZSQ3JDAuNTkiLCJkb2N1bWVudCQ4JDljOTc5ODUyIiwiY29ubmVjdGlvbiQ4JCIsImRvd25saW5rTWF4JDgkIiwiZ2V0VXNlck1lZGlhJDgkMiIsImNsb2NrJDEyJDQ0OTUiLCJiYXR0ZXJ5JDI4JDEgMSAwIEluZmluaXR5IiwiYXVkaW9jb250ZXh0JDYzJGFmZTRmOWM0IiwiaW50ZXJzZWN0aW9uLXNpemUkNjMkMTU4NXgxMjAwIiwiaW50ZXJzZWN0aW9uLWVudGVyJDYzJDAuNXgwIDcyOHgwIiwiaW50ZXJzZWN0aW9uJDYzJDEwMCIsInNvcnQkODgkMTEuOTMiLCJmcmFtZXJhdGUkMTE5JDYw
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:82de:3dbd:aba5:8158 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-52-13-54-247.b2c.com/api/ 		0
382 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-52-13-54-247.b2c.com/api/x?WHjlZadNwGfgCYL3$YWRibG9jayQ1NDckMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:4696:4121:90e8:18d3 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:02 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame B0D5 		42 B
274 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjst-EKqlKu2tqb9Vw4z-dJHgY-pKRtVCIEVSuijBFfpN3DOLUDAE8uZ9cQ3UsQ1o1DaLjlYVD0XTmPqfmbTl8NkRsIsBRgFjiruOFEkkStc&sig=Cg0ArKJSzAVOldfj5zBAEAE&adk=3073216299&tt=1171&bs=1585%2C1200&mtos=1043,1043,1043,1043,1043&tos=1043,0,0,0,0&p=140,428.5,230,1156.5&mcvt=1043&rs=3&ht=0&tfs=832&tls=1875&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=761&niot_cbk=774&md=2&rst=1567914661730&rpt=54&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C4096&ss=1600%2C1200&pt=708&bin=1&deb=1-1-4-20-18-11-44-17-0-0-0&tvt=1871&r=v&id=osdim&vs=4&uc=10&upc=0&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=728x90&itpl=3&v=20190904
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:02 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
x
api-34-220-54-177.b2c.com/api/ Frame 35A2 		0
382 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-34-220-54-177.b2c.com/api/x?WWoJ47WuUZmunRpx$YWRibG9jayQ1MzgkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5802:a3d2:ff9c:62:f338 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
activeview
pagead2.googlesyndication.com/pcs/ Frame C8FB 		42 B
110 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjssR3FnwuRYpd4mUPHAk_CDmgGpTKRwCVKPhq5EyeQuyS10J_PkSpQ8l8AODEcU18k_-9ozShnkrqgv-VPlT_R8H0BDNHS7HaID2v1dIImw&sig=Cg0ArKJSzKKJU02Y-icKEAE&adk=2374356963&tt=1383&bs=1585%2C1200&mtos=1016,1016,1016,1016,1016&tos=1016,0,0,0,0&p=305,1052.5,905,1352.5&mcvt=1016&rs=3&ht=0&tfs=1072&tls=2088&mc=1&lte=1&bas=0&bac=0&met=0&avms=nio&niot_obs=945&niot_cbk=971&md=2&rst=1567914661911&rpt=56&isd=0&msd=0&lm=2&oseid=3&xdi=0&ps=1585%2C4096&ss=1600%2C1200&pt=708&bin=1&deb=1-1-4-25-20-11-54-19-0-0-0&tvt=2083&r=v&id=osdim&vs=4&uc=10&upc=1&tgt=DIV&cl=1&cec=1&clc=1&cac=1&cd=300x600&itpl=3&v=20190904
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE - Google LLC, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

pragma
no-cache
date
Sun, 08 Sep 2019 03:51:03 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
status
200
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
content-type
image/gif
alt-svc
quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43,39",quic=":443"; ma=2592000; v="46,43,39"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
x
api-54-185-17-100.b2c.com/api/ Frame C8FB 		0
382 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-54-185-17-100.b2c.com/api/x?N0OC5fhexkh01EES$YWRibG9jayQ2NTkkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:1332:efe2:4c8b:e1bc Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
x
api-35-164-230-125.b2c.com/api/ Frame B0D5 		0
382 B 		Other
General
Check archive.org
Download Go to
Full URL
https://api-35-164-230-125.b2c.com/api/x?VvXUIDQnkRauUX0a$YWRibG9jayQ5NDMkMA
Requested by
Host: www.empr.com
URL: https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
2600:1f14:e96:5800:82de:3dbd:aba5:8158 Boardman, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
Software
openresty /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Sun, 08 Sep 2019 03:51:03 GMT
Server
openresty
Transfer-Encoding
chunked
Access-Control-Allow-Methods
GET, POST, OPTIONS
Content-Type
text/plain
Access-Control-Allow-Origin
https://www.empr.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Expires
-1
close_button2.png
cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/ 		1 KB
2 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://cdn1.spotible.com/hashed/74483a4bff0849849588dbf32a396fe9/close_button2.png
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
143.204.214.77 Seattle, United States, ASN16509 (AMAZON-02 - Amazon.com, Inc., US),
Reverse DNS
server-143-204-214-77.fra53.r.cloudfront.net
Software
/
Resource Hash
f42e34b205a7c2ac4a0997e0b1eb2627e76ee8ae15ac7a15b05954827e186dd9

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

date
Fri, 06 Sep 2019 08:58:04 GMT
via
1.1 cc77875ec7dfc885cffaa2ec6fa578f6.cloudfront.net (CloudFront)
age
154381
etag
"74483a4bff0849849588dbf32a396fe9"
x-cache
Hit from cloudfront
status
200
cache-control
public, max-age=604800
x-amz-cf-pop
FRA53-C1
accept-ranges
bytes
content-length
1429
x-amz-cf-id
vxvOJhMcsmTg8eWmWcmgVaFT4JZF-H-XDpG1hqSroaqR3rjJ15Cc9Q==
report
ads.spotible.com/creative/bmMb/ 		43 B
191 B 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://ads.spotible.com/creative/bmMb/report?,1567914661,596003;IMPRESSION!4,1,0!5,1,0
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.197.62.58 Ashburn, United States, ASN14618 (AMAZON-AES - Amazon.com, Inc., US),
Reverse DNS
ec2-34-197-62-58.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Sec-Fetch-Mode
no-cors
Referer
https://www.empr.com/home/news/drugs-in-the-pipeline/twice-yearly-cholesterol-lowering-therapy-effective-in-phase-3-trial/?utm_source=newsletter&utm_medium=email&utm_campaign=mpr-dailydose-dmd-20190908&cpn=im_all,pcp_all,PVC2019127035,pcp_md,EmaglityMMJuly30DMD,EmaglityLMNL_Aug28DH&hmSubId=&hmEmail=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0&NID=1518074491&c_id=&email_hash=44dea3cd4839b799f2911b5d7920d77d&dl=0&mpweb=1323-67302-5059933
User-Agent
Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/74.0.3729.169 Safari/537.36

Response headers

Date
Sun, 08 Sep 2019 03:51:05 GMT
Cache-Control
no-store
Connection
keep-alive
Content-Length
43
Content-Type
image/gif

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
tpc.googlesyndication.com
URL
https://tpc.googlesyndication.com/safeframe/1-0-35/html/container.html

Verdicts & Comments Add Verdict or Comment

199 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

number| pamEnabled object| hmAds object| dataLayer object| $ function| jQuery function| cookie object| _cc14413 object| LOTCC object| Digest function| UtilityMove object| core object| __core-js_shared__ object| global object| System function| asap function| Observable function| setImmediate function| clearImmediate object| regeneratorRuntime boolean| _babelPolyfill object| googletag object| ggeac object| closure_memoize_cache_ object| googleToken object| googleIMState object| google_js_reporting_queue function| processGoogleToken object| google_tag_manager string| GoogleAnalyticsObject function| ga string| adTrackProxyPath string| advertTrackingApiUrl boolean| trackImpressionsViewable object| clickedAd boolean| isOverIFrame object| dfpRequests function| waitFor function| DataLayerExist function| AdSlotsRegistered function| TrackPassbackImpression function| TrackImpression function| TrackImpressionViewable function| AdClick function| checkDuplicateImpression function| callApi function| AmazonWebService function| createAdTrackingMessage function| getAJAXObject function| trackAdvert function| xdTrackAdvert function| getRenderedAd function| EventType function| getPageDetails function| getPageName function| getSection1 function| getPageType function| getDevice function| getValueFromTargets function| getPageTypeId function| getBrowser function| getUser function| getDfpTimestamp function| getCookies function| getTimeStamp function| ProcessMouseOut function| ProcessMouseOver function| processIFrameClick function| getDfpUrlFor function| getDfpUrls function| logAdvertRequested object| dataLayerService function| hmHeaderLoginState object| dfpAdSlots object| mapping object| adSlotsConfig object| allowedSlots string| hmHomeUrl string| hmAccountUrl object| hmRegisteredAds boolean| hmAdsLazyload number| hmAdsActiveRefresh boolean| hmAdsCommentsHouse boolean| hmDmdAimEnabled boolean| hmProclivityEnabled boolean| hmAdsActiveRefreshAll boolean| hmAdsBoxReposition boolean| hmAdsLytics object| adSlots number| adDebug object| hmProclivity string| cpn object| haymarketCustomEvents string| redirect object| google_tag_data object| gaplugins object| gaGlobal object| gaData object| epas function| maropostInitTracking string| name_funnel function| _132350 string| name_funnel1 function| _13235 object| data object| ids object| epasAPI object| hm_localize object| hm_gated object| date function| isStorageSupported function| truncateItem function| storeData function| removeData function| retrieveData function| readStorage function| getExpiration object| CE2 string| __INDIVIDUAL_ONE_VERSION_ev-store_ENFORCE_SINGLETON undefined| __INDIVIDUAL_ONE_VERSION_ev-store object| TenUp object| liosetup object| jstag object| hmAuthNoncePromise function| disqus_config object| hmRegisterPrompt function| hmSetLyticsData undefined| google_measure_js_timing boolean| google_DisableInitialLoad boolean| google_noFetch number| __google_ad_urls_id object| adblockDetector object| pageVars object| _atrk_opts function| fbq function| _fbq function| retry function| isIE10OrLater function| detectPrivateMode object| wp function| hmOpenRegisterPrompt function| webpackJsonp object| AIM object| _ml object| google_optimize function| __jstag_onload undefined| initObj string| ly_cid function| atrk boolean| _atrk_fired object| ns_ object| lio string| set_domain function| domain_name function| deleteMaroClickScriptTag function| maroRecordClick function| anchor_event_add function| maroRecordTime function| maroTrackInit function| HMIRegistration object| ssoLogin object| ssoRegister object| _0xee07 function| _0x5513 object| optimizely object| pathfora function| ttd_dom_ready function| TTDUniversalPixelApi number| google_unique_id object| google_reactive_ads_global_state function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter object| __google_ad_urls object| ampInaboxIframes object| ampInaboxPendingMessages boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| prontoTags object| ProntoCE object| ProntoDOMEvents object| gtm string| string1 string| string2 string| string3 string| string4 string| string5 string| string6 string| string7 string| string8 string| string9 string| string10 number| lySegmentCounter string| result string| key function| checkForCPNSegments function| logit function| __$PP

40 Cookies

Domain/Path Name / Value
www.medtargetsystem.com/ Name: DMDSESSID
Value: 48gevv5p7bjco29arrvgahdlo2
www.empr.com/ Name: dmd-3d4294db-87ee-4229-bc33-7532747fbd17
Value: e30=
.empr.com/ Name: __gads
Value: ID=5feed609881dd5e5:T=1567914660:S=ALNI_MZZ1jje7zxoPM3WFeDBk7Iay47qbQ
www.empr.com/ Name: PathforaTest_eba13817e4cda2f9087c77f4803500dc
Value: 0.5060189144945824
www.empr.com/ Name: PathforaTest_d32aacecfe87458780ba0a5b22e84019
Value: 0.16581239361007305
www.empr.com/ Name: PathforaTest_853e3ee5e01881b83ab49fe8c2eae359
Value: 0.9769210275521156
www.empr.com/ Name: PathforaTest_845520b7c2ad6c7b2d753bf3b76b1546
Value: 0.512807792746824
www.empr.com/ Name: PathforaTest_6bc045766412f0ca499172958fc3e795
Value: 0.9584683088051309
www.empr.com/ Name: PathforaTest_354ff931e1d1ba292afc8446d8447661
Value: 0.9820074135714265
www.empr.com/ Name: PathforaTest_fbcdd6902623329bbdbacbed41b3575a
Value: 0.7838616833681151
www.empr.com/ Name: PathforaTest_16c648a7e9a8e384a49983317da2418c
Value: 0.1554453925224506
www.empr.com/ Name: PathforaPageView
Value: 1
www.empr.com/ Name: _sess
Value: 3d4294db-87ee-4229-bc33-7532747fbd17.35d939d2-3d95-4ff6-bfd1-e4e8023a3c29.1567914659.1
www.empr.com/ Name: _ccmaid
Value: 5978151495441525110
.www.empr.com/ Name: seerid
Value: 1b8b3958c6e84842b6c08f6862b387a5
www.empr.com/ Name: dmd-ahk
Value: 7074761af4
.empr.com/ Name: seerid
Value: 1b8b3958c6e84842b6c08f6862b387a5
www.empr.com/ Name: register-pages
Value: 1
.empr.com/ Name: _maro_campaign_id
Value: BAhpA+YGAQ==--00bf897165681b7df2c34ce78048f783cda6a105
www.empr.com/ Name: _ccmsi
Value: 1567914659970_x0yckoqnp|1567914659970
.empr.com/ Name: _maro_account_id
Value: BAhpAisF--37e0a5dc91bbd179df584d1ded7f2656371a9960
www.empr.com/ Name: PathforaTest_2c3134d8bbcf5fc7ef88d4f188d3d27a
Value: 0.8845816920182363
www.empr.com/ Name: dmd-sid
Value: 3d4294db-87ee-4229-bc33-7532747fbd17
www.empr.com/ Name: hmSsoCheck
Value: true
.www.empr.com/ Name: seerses
Value: e
www.empr.com/ Name: hmNpiId
Value: 1518074491
.empr.com/ Name: __asc
Value: 9e84c6cf16d0eff102bfb635a9a
.empr.com/ Name: _maro_contact_id
Value: BAhpA101TQ==--9cd672c348552200f873f09fa8840e8d9f29f654
.empr.com/ Name: __auc
Value: 9e84c6cf16d0eff102bfb635a9a
.empr.com/ Name: _gat_UA-1290429-2
Value: 1
.empr.com/ Name: seerses
Value: e
www.empr.com/ Name: hmUsrc
Value: haymarket
www.empr.com/ Name: PathforaTest_c835c8fce5cb8c9ae765bcc82e287892
Value: 0.9826051606144088
.empr.com/ Name: _fbp
Value: fb.1.1567914659917.899085242
.empr.com/ Name: _gid
Value: GA1.2.1002369859.1567914660
.empr.com/ Name: _ga
Value: GA1.2.1173771773.1567914660
www.empr.com/ Name: spinfo
Value: spem=HU98C-HUyjjIe45OpSV_2LHyQK-UaGQT0
www.empr.com/ Name: PathforaTest_00a2fe23f73e4b2dcdcaba9058b0c8da
Value: 0.7942681513016989
www.empr.com/ Name: dmd-vid
Value: 35d939d2-3d95-4ff6-bfd1-e4e8023a3c29
www.empr.com/ Name: adcpn2
Value: im_all%2Cpcp_all%2CPVC2019127035%2Cpcp_md%2CEmaglityMMJuly30DMD%2CEmaglityLMNL_Aug28DH

77 Console Messages

Source Level URL
Text
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1(Line 2)
Message:
JQMIGRATE: Migrate is installed, version 1.4.1
console-api log URL: https://s3.amazonaws.com/haymarket-adtracking-js/prod/adtracking.js(Line 540)
Message:
interactive
console-api log (Line 2)
Message:
DMD AIM data:{}
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] start beginTest
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] adding bait node to DOM
console-api log (Line 8)
Message:
logit -ga_med_nomycme
console-api log (Line 8)
Message:
logit -ga_med_nht_false
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_rheum_survey_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(3_day_visitors_neuro_ca_empr)
console-api log (Line 6)
Message:
checkForCPNSegments(blackfriday_notunknown)
console-api log (Line 6)
Message:
checkForCPNSegments(activity_5126_audience)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_endofyearsale_noanonymous_nosdc)
console-api log (Line 6)
Message:
checkForCPNSegments(audience_for_mlk_sale)
console-api log (Line 6)
Message:
checkForCPNSegments(not_unknown_5770)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5762)
console-api log (Line 6)
Message:
checkForCPNSegments(ddw_opened_to_all)
console-api log (Line 8)
Message:
logit -all
console-api log (Line 6)
Message:
checkForCPNSegments(all)
console-api log (Line 6)
Message:
checkForCPNSegments(smt_new)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_has_visited_web)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_multi_session_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_day)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_week)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_month)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_reporting_last_visit_within_3_months)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_unknown_email)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_repeat_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_international_visitor)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_uses_desktop)
console-api log (Line 6)
Message:
checkForCPNSegments(ly_from_email)
console-api log (Line 6)
Message:
checkForCPNSegments(all_time_visitors)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4797_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_hiv_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_internal_med_all_except_4670_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_allergy_all_except_4744_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_psychiatry_all_except_4812_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_cardiology_all_except_cardiology_pas)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_dermatology_all_except_4831_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_all_except_4354_completes)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4523)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4524)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4525)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4526)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4593)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4595)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4710)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4804)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4834)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4800)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4792)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4511)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4529)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4558)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_acc_next_activity_promo_no_4634)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4740)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4757)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4842)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4816)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4897)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4727)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4755)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4791)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_47911)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4826)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_impact_next_activity_promo_no_4815)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_mpr_print_subscribers)
console-api log (Line 6)
Message:
checkForCPNSegments(ce_excluding_ca_print_subscribers)
console-api log (Line 8)
Message:
logit -ga_med_unknown
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_homepage_ibs_town_wall_)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_ddw_nash)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_activity_5841_2)
console-api log (Line 6)
Message:
checkForCPNSegments(mycme_pediatrics_activity_5591)
console-api log (Line 5)
Message:
OK
console-api log URL: https://1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com/wp-content/themes/haymarket/dist/js/iab.min.js?ver=1567085297(Line 1)
Message:
[ABD] exiting test loop - value: false

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

1au3b422k9zdqzddw3my51gg-wpengine.netdna-ssl.com
accounts.haymarketmedia.com
ads.spotible.com
adservice.google.com
adservice.google.de
adtrackapi.haymarketmedia.com
api-34-220-54-177.b2c.com
api-35-164-230-125.b2c.com
api-52-13-54-247.b2c.com
api-54-185-17-100.b2c.com
api.b2c.com
api.lytics.io
bcp.crwdcntrl.net
c.lytics.io
cdn1.spotible.com
certify.alexametrics.com
connect.facebook.net
content.maropost.com
d31qbv1cthcecs.cloudfront.net
fonts.googleapis.com
fonts.gstatic.com
idsync.rlcdn.com
in.ml314.com
insight.adsrvr.org
js.adsrvr.org
link.email.empr.com
ml314.com
mpct1.maropost.com
mt.sitomobile.com
pagead2.googlesyndication.com
pixel.mathtag.com
pixel.tapad.com
ps.eyeota.net
s3.amazonaws.com
sb.scorecardresearch.com
script.crazyegg.com
securepubads.g.doubleclick.net
sp.sitomobile.com
stats.g.doubleclick.net
subapi.haymarketmedia.com
sync.crwdcntrl.net
tags.bluekai.com
tags.crwdcntrl.net
tpc.googlesyndication.com
www.empr.com
www.facebook.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
www.medicalbag.com
www.medtargetsystem.com
tpc.googlesyndication.com
104.111.214.103
104.111.241.32
143.204.207.113
143.204.214.113
143.204.214.37
143.204.214.77
172.217.22.98
18.195.52.121
2.18.233.201
2600:1f14:e96:5800:1332:efe2:4c8b:e1bc
2600:1f14:e96:5800:82de:3dbd:aba5:8158
2600:1f14:e96:5802:3864:1186:98a:22d7
2600:1f14:e96:5802:4696:4121:90e8:18d3
2600:1f14:e96:5802:a3d2:ff9c:62:f338
2600:9000:2057:5e00:16:bc48:4dc0:93a1
2600:9000:2057:b600:1b:fadc:b780:93a1
2606:4700:20::6819:5365
2606:4700::6813:9408
2a00:1450:4001:809::200a
2a00:1450:4001:819::2008
2a00:1450:4001:81c::2004
2a00:1450:4001:81d::2002
2a00:1450:4001:81e::2003
2a00:1450:4001:825::2001
2a00:1450:4001:825::2003
2a00:1450:4001:825::200e
2a00:1450:400c:c06::9a
2a03:2880:f02d:12:face:b00c:0:3
2a03:2880:f12d:83:face:b00c:0:25de
3.226.58.85
3.248.146.79
34.197.62.58
34.220.54.177
34.225.65.223
34.233.109.111
34.252.62.73
35.164.230.125
35.172.78.117
35.174.96.0
35.190.72.21
35.227.192.113
35.227.248.159
35.238.92.4
52.1.219.33
52.13.54.247
52.206.48.92
52.216.115.21
52.4.150.177
52.51.120.75
54.185.17.100
54.76.79.46
93.184.220.113
94.31.29.64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